Development of a microfluidic platform and detection system for platelet function analysis by Kent, Nigel J.
Dublin City University
School of Mechanical and Manufacturing Engineering
A Thesis Presented For The Degree Of Doctor Of Philosophy
Development of a Microfluidic
Platform and Detection
System for Platelet Function
Analysis
by
Nigel J. Kent B.Eng
Supervisors: Dr. Brian Corcoran
Prof. Brian MacCraith
Dublin, 2009
Declaration
I hereby certify that this material, which I now submit for assessment on
the programme of study leading to the award of Doctor of Philosophy is
entirely my own work and has not been taken from the work of others save
and to the extent that such work has been cited and acknowledged within
the text of my work.
Signed: (Candidate) ID No.
Date:
ii
”The first principle is that you must not fool yourself
- and you are the easiest person to fool.”
Richard P. Feynman
Acknowledgements
This body of work would not have been possible without a number of sig-
nificant inputs, across a range of disciplines. Firstly, and most importantly,
I would like to thank my ’team’ of research supervisors. While some people
are lucky enough to study under a single accomplished supervisor, I was
extremely fortunate to study under, effectively though unofficially, three.
Brian Corcoran, your ability to immediately deconstruct problems and
identify the fundamental issues with such clarity, was of immeasurable ben-
efit over the last few years.
Brian MacCraith, your constant drive and refusal to rest on the many
laurels you have, was a constant source of inspiration throughout this work.
It is a quality to which I can only aspire and hope it is somewhat reflected
in this work.
Finally to Tony Ricco, your breath of knowledge across seemingly unre-
lated topics was invaluable. Further, your willingness to assist, at all hours
of day and night, and your ability to explain abstract concepts in just the
right way has left its mark throughout this body of work.
In terms of all things platelet related, my thanks go to the Royal College
of Surgeons in Ireland. Particularly to Gerardene Meade, your patience in
explaining the most fundamental aspects of platelet biology, and willingness
to put others before yourself have progressed this body of work more than
iv
you can know. My thanks also go to Dermot Kenny for taking a chance
and letting an engineering influence permeate through his lab. To say your
enthusiasm for this work was infectious, is an understatement. Thanks also
go to Sinead O Brien, always on hand to carry out experiments, just to
satisfy my curiosity, even if some were crude and primitive!
Further acknowledgements also go to the students and staff of the Biomed-
ical Diagnostics Institute and National Centre for Sensor Research, based in
Dublin City University, for providing a challenging and extremely reward-
ing working atmosphere. Particular thanks to the lads in S103 (past and
present), scones just don’t taste the same anymore!
Particular thanks also goes to Celine Heffernan for bending countless
rules in her willingness accommodate me with non-scientific delays to the
progression of this work. Also, a big word of thanks goes to Barry O’Connell
for his patience with all things electronics. It can’t have been easy watching
me blow up all those components.
Thanks must also go to my family and friends for the frequent reminders
that I am, in fact, a nerd. I should say this fact had never escaped me, but
your reminders at least showed you cared enough to also know. For family
and friends who have read this far, I was joking you don’t have to read this.
Thanks also to the funding agent for this work:
This work was supported by Science Foundation Ireland under Grant
No. 05/CE3/B754.
Abstract
This work details the development a point-of-care diagnostic sensor system
for early warning of diseases or disorders that involve changes in the acti-
vation state of platelets. The sensing system tracks the changes in platelet
coverage on a well characterised Von Willebrand Factor coated surface us-
ing customised image analysis to objectively quantify fluid-shear-mediated
platelet-surface interactions for statistically meaningful numbers of platelets
from a single blood sample. A novel mass-manufacturable microfluidic de-
vice provides well-defined shear at the surface and hydrodynamically focuses
the sample stream into contact with the surface, providing assay results from
< 200 µL of undiluted whole blood. The custom detection system integrates
low-cost optical components with fluidic and thermal control components
for stand-alone fluorescence-based platelet assay in whole blood.
The developed sensor system was validated using surface coverage anal-
ysis from ’normal’ blood samples compared to samples treated with ReoPro
(abciximab or c7E3 Fab): ReoPro treatment inhibits the α IIbβ3 recep-
tor on the platelet surface, thus interfering with stable adhesion to VWF,
rendering platelets ”less sticky.” A similar assay could prove diagnostic for
platelet dysfunction in interactions with alternative vascular matrices and
facilitate study or diagnosis of thrombosis. This approach will also enable
the study and diagnosis of the effects of platelet drug treatment under con-
trolled fluid shear conditions.
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Chapter 1
Introduction
Cardiovascular disease (CVD) resulted in almost one third of global deaths
in 2003 and by 2010 will be the leading cause of death in developing coun-
tries [1]. Cardiovascular events, such as heart attack or stroke, are caused
by thrombosis, i.e. the formation of clots which occur as a result of blood
platelet activation. The events initiating thrombosis after vessel injury or
plaque rupture are now relatively well understood [2]. Although thrombosis
is prevented in part by aspirin and anti-platelet agents, heart attacks and
stroke still occur frequently. This suggests that platelet behaviour in indi-
viduals differs, as does individual response to platelet therapy. In particular,
it is difficult to predict those individuals likely to suffer from cardiovascular
disease or cardiovascular events.
Unfortunately, platelets are only suited to meaningful functional analysis
for approximately four to six hours after being taken from the body. The
process of preparing platelets for ex vivo experimentation shortens this time
span. In view of this limitation, typically, only a small number of tests can
be performed using prepared platelets. In turn, such studies only provide a
small amount of relevant information on platelet function. As a result it is
still unclear what constitutes normal platelet function.
1
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The ability to characterise platelet function under haemodynamically
relevant conditions would be of benefit, as it would yield valuable prog-
nostic, diagnostic and therapeutic information. In particular, the ability to
assess platelet function rapidly in the clinic or at the bedside, and more par-
ticularly, without any biochemical preparation or alteration of the platelets
following their removal from the body, would allow for a more accurate pre-
diction of cardiovascular risk. It would also enable tailoring of anti-platelet
therapy to the needs of an individual patient in order to minimise the risks
of thrombosis and bleeding.
1.1 Platelets
Platelets or thrombocytes are small discoid (2-4 µm by v 0.5 µm) cell
fragments that circulate in the blood stream and are involved in the cellu-
lar mechanisms of haemostasis leading to the formation of blood clots [3].
They are the second most numerous corpuscle in the blood with a concen-
tration between 150 - 400 x 109/L and can circulate in the bloodstream
for approximately 10 days [4]. Due to their shape and size, particle fluid
dynamics dictates that platelets will travel close to the endothelial layer of
a vessel wall [3]. This endothelial layer is a thin layer of cells which line
the circulatory system and provide an interface between circulating blood
and the rest of the vessel wall. Under normal conditions, the endothelium
provides a non thrombotic surface, promoting blood flow. However, if the
endothelium becomes altered or the vessel wall damaged, a combination of
extracellular proteins become exposed, regulating a complex functional re-
sponse in platelets, which results in the rapid formation of a platelet plug
that occludes the site of injury to prevent blood loss. The response de-
pends on the extent of the damage, the matrix proteins exposed and the
flow conditions of the blood [7]. From a fluid mechanics perspective, among
2
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Figure 1.1: Basic platelet interactions
the more critical of these flow parameters has been shown to be the shear
force generated at the vessel wall [8, 9]. This has significant implications,
particularly in the case of atherosclerotic stenosis [10] where the increase in
blood flow velocity through the narrowing of the artery causes an increase
in shear forces generated promoting thrombus formation which can lead to
myocardial infarction or stroke. As a result, the mechanisms that support
platelet activation and aggregation under conditions of high shear force are
currently of particular interest in thrombosis research.
The entire mechanism of platelet activation and aggregation is complex
with many interdependent biochemical processing occurring simultaneously.
However, the three main processes are summarised in Figure 1.1.
1. Activation. On detection of vascular damage, platelets are initially
bound to the surface via interactions between Von Willebrand Factor
3
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(VWF), released by the damaged endothelium, and Glyco protein
Ib/IX/V (Gp Ib/IX/V) on the platelet surface. This interaction slows
the platelets and causes a characteristic translocating or rolling of
the platelets along the damaged surface. This VWF - Gp Ib/IX/V
interaction has been shown to be highly shear force dependent [8].
2. Adhesion. As the platelets slow under shear-force, the interaction
between the exposed collagen at the site of injury and Gp VI on the
activated platelet surface cause the platelets to firmly adhere to the
damaged vasculature.
3. Aggregation. This adhesion results in intracellular signalling and re-
lease of pro-coagulants, thereby promoting further platelet recruit-
ment to the damaged area resulting in the formation of a platelet-
platelet aggregates mediated by fibrinogen binding to Gp IIb/IIIa.
If there is a defect in any of these interactions or there are other abnor-
malities resulting in a low platelet number, haemostasis can be affected and
increased bleeding may result. In contrast, if the platelet count is abnor-
mally high this can lead to unnecessary thrombus formation increasing risk
of CVD and other platelet function related disorders such as cancer [11].
As a result, the need for platelet function analysis systems is currently of
critical importance. Traditionally, platelet function tests have been used to
specifically identify potential causes of abnormal bleeding [12]. However,
recent advances in medical diagnostics and trends towards point of care
devices have led to the development of a small number of devices being
developed to investigate alternative aspects of platelet function.
4
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1.1.1 Platelet Function Analysis Systems
Current State of the Art
Although there is a significant volume of laboratory based literature avail-
able on platelet function analysis, there still remains relatively few sys-
tems for platelet function analysis commercially available. Recent publica-
tions [7, 12, 13] have independently discussed a selection of commercially
available platforms. The following section summarises some of the better
characterised platelet function tests while a more comprehensive list can be
found in Appendix A.
Figure 1.2: Light Transmission Aggregometry
The current gold standard test for platelet function is Light Transmission
Aggregometry (LTA). Figure 1.2 illustrates the general principle of LTA. A
platelet-rich plasma sample is stirred in a cuvette and light transmission
through the platelet medium is measured. A potential platelet agonist is
added and, as the platelets aggregate, the light transmission through the
platelet carrying medium is increased until a plateau is reached indicating
maximum platelet aggregation. By adding a series of agonists over a range
5
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of concentrations it is possible to obtain a large amount of data in relation
to different aspects of platelet function.
Unfortunately, the standard aggregometer test is limited in that the
procedure takes a considerable amount of time to perform and significant
sample volumes and preparation are required. Also, LTA systems are gener-
ally expensive and, as a result, use of these systems is typically confined to
specialised laboratories. Furthermore, aggregometry is not a measure solely
or simply of platelet activation status. The aggregation process depends
on a complex biochemical and physical sequence, of which platelets are one
key part.
The PFA (platelet function analyzer)-100 TM device measures time to
clotting (known in this case as closure time) after exposure of whole blood
to collagen and epinephrine (CEPI) or collagen and ADP (CADP). Anti-
coagulated whole blood is drawn under vaccuum through a stainless capil-
lary. The high shear forces generated initiate platelet activation. The blood
then passes through a small aperture in a membrane coated in either CEPI
or CADP (see Figure 1.3). The high shear forces promote initial adhesion
of the platelets to this membrane and subsequent biochemical interactions
cause the platelets to aggregate and block or ’close’ the small aperture re-
stricting blood flow. While the transduction method is relatively simple,
there are many factors which affect closure time such as platelet count,
hematocrit levels and baseline measurement of von Willebrand factor in
plasma. As a result, a single output of time to closure from such a device
may not be an accurate representation of purely platelet function. Further,
comparison of the results provided by a PFA-100 TM device with those of
the gold standard platelet function test indicates differences [7] and thus
the PFA-100 TM device has limited suitablility.
The Accumetrics Verify Now TM device can be used at the bedside and
uses whole blood to assess platelet function. This device represents a signif-
6
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Figure 1.3: PFA100TM (shown left) and Verify NowTM (shown
right)Schematic
icant advance towards a Point of Care type diagnostic device. The device
is based on light aggregometry but provides an advantage over the gold
standard in that the measurements can be performed in whole blood. The
disposable Verify NowTM cartridge consists of an inlet for connection to a
standard vacutainer used for blood draws. The blood is then divided into
four chambers. Inside the chambers are a steel ball to promote mixing and
polystyrene beads coated with platelets agonists (See Figure 1.3). When
the blood is introduced into the chambers, the platelets begin to aggregate
and light transmission through the chambers is measured as previously de-
scribed. However, as previously stated, aggregometry is not solely a measure
of platelet function as many processes occur simultaenously, also as for the
PFA-100 TM device, this device also only provides a limited amount of infor-
mation regarding platelet reactivity. Further, the Verify NowTM cartridges
are inflexible and are currently only available for platelet function analysis
in response to Aspirin, Clopidogrel and response to changes in Gp IIb/IIIa.
Diamed - Impact-R is a device for testing platelet function under close
to physiological conditions. This device tests shear-force mediated platelet
adhesion and aggregation in anti-coagulated whole blood under arterial flow
7
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conditions. The Impact-R can be used to study platelet function, screen-
ing of primary haemostasis abnormalities and provides a quick method for
monitoring platelet response to various anti-platelet drugs. For standard
operation, 130 µL of whole blood is placed in a well and a defined shear
rate of 1800s−1 is applied via a cone plate appendage as part of the device
(See Figure 1.4).
Figure 1.4: Diamed - Impact-R Schematic
This shear is applied for 120 secs and the plate is then washed and the
remaining platelets stained and imaged under a microscope housed within
the Impact-R device. Since this is only a relatively new apparatus there is
little widespread experience of its use. However, while the test conditions of
the Impact-R are hemodynamically relevant, the device ultimately measures
a single time point of a highly dynamic process. This results in a significant
amount of potentially valuable data being undetected by the device.
Research-based tests for platelet function vary depending on the partic-
ular aspect of platelet function under investigation. For experiments involv-
ing shear-mediated response in platelets the standard metrics used are cone
plate viscometry or parallel plate flow devices (See section 1.2.1). While
many research groups use custom-designed chambers, parallel plate devices
are commercially available from Glycotech [14]. The chambers currently
provided, require assembly to form the complete chamber and also require
the use of a vacuum pump to form a seal of the chamber components: a top
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plate (or flow deck), silicon rubber gaskets (the dimensions of which, form
the flow path area) and glass coverslips. For clinical haemodynamic studies,
the assembly of the flow chambers and sample provision is technically labori-
ous and requires training. In addition, the volume of blood sample required
for haemodynamic studies is considerable. Furthermore, these flow cham-
bers normally require use with relatively expensive fluorescent microscopy
suites requiring environmental stability control. This extraneous hardware
typically confines the use of these parallel plate flow chambers to specialised
laboratories.
An additional characteristic of these systems, however, is the ability to
generate a significant amount of data from a single experiment. The data
are typically in the form of fluorescent images taken at user defined inter-
vals over a flow run. At appropriate magnifications these data sets can
contain both platelet-specific data and information pertaining to the entire
platelet population of the donor. To date however the analysis of these
data sets has proved challenging; for example, in the case of platelet mo-
tions generic rules for particle tracking does not apply and the Gp Ib/IX/V
- VWF interaction is largely independent of sample volume and so the as-
sumptions made by particle image velocimetry do not apply. Also many of
the commercial image processing packages are geared toward the analysis
of adhered cells or constituents of the sub-cellular matrix. Although there
is some literature relating to image based platelet function analysis [6] this
typically involves significant sample manipulation such as platelet dilutions
or laborious manual image analysis on only a fraction of the captured data.
To highlight some of the current problems in relation to platelet function
testing, a recent official communication by the scientific and standardisation
committee of the International Society on Thrombosis and Haemostasis [15],
published a series of points highlighting the current issues with use and
development of the current flow tests used to evaluate bleeding risk. Among
9
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the points were:
1. Use of controlled (quantity of) collagen as adhesive substrate
2. Use of different shear rates
3. Use of non-anticoagulated blood, preferably at physiological cation
concentrations
4. Use of single-pass, small capacity flow devices
5. Time-dependent measurement of thrombus build-up
While the list was specifically generated with a view towards VonWille-
brands disease, many of the points are of a generic nature and are applicable
to many platelet function assays. In short, the communication highlights
the need for controlled platelet agonist substrates, tunable shear rates, use
of small volumes of non - anticoagualted blood for time dependent measure-
ments. With a view to the development of Point of Care systems, inherent in
these suggestions is the requirement for low cost, robust, integrated readout
and analysis systems.
1.2 MEMS development
The last number of years have seen a marked increase in the field of mi-
croelectromechanical systems (MEMS) and microfabrication technologies.
The earliest embodiments of these devices are now in every day use in many
facets of the world around us. Instruments as apparently diverse as inkjet
printers and airbag deployment sensors have all been enabled by develop-
ments in the rapidly expanding area of microsystems technology ∗.Many of
∗The area of microelectromechanical systems (MEMS) is also known as microsystems
technology (MST) and can also be, although predominantly in Japan, termed microma-
chines.
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the enabling technologies for this increase in MEMS development can be
largely attributed to the semiconductor industry where the requirement for
improved speed and efficiency of devices became significantly important,
particularly for integrated circuits. While MEMS devices have built on the
already existing semiconductor technologies the field has rapidly expanded
and many new MEMS specific techniques have been developed. This in turn
has facilitated microsystems technologies being applied across a number of
diverse fields, in particular to the area of life sciences.
In parallel with the development of next generation MEMS has been
the advances made in the area of microfluidics. Microfluidics is a broad
term encapsulating the control, behaviour and understanding of volumes
of fluids in the pico-microlitre range. On this scale, the macroscopic be-
haviour of physics does not necessarily hold true as other effects typically
begin to influence the system. Surface to volume ratios of fluids in MEMS
devices tend to be dramatically different from those in the macro world and
causes surface effects, such as electrostatics, to dominate over inertial effects.
Viscous forces also typically dominate over inertial forces, resulting in low
Reynolds numbers which is characteristic of most microfluidic MEMS de-
vices. Among the main practical implications of these low Reynolds number
systems is that fluid behaviour remains in the laminar regime. This results
in mixing on the micro scale being a primarily diffusive process. As with
many apparent peculiarities on the microscale this effect can be exploited to
develop new technologies or compensated for where the effect is detrimental
to the function of the overall system [16].
Of particular interest in recent years has been the evolution and applica-
tion of biological microelectromechanical systems (Bio-MEMS). In conjunc-
tion with basic MEMS components such as microchannels, microvalves, mi-
cropumps and micromixers, Bio-MEMS offers the ability to integrate many
laboratory functions on a single low cost device. These ’Lab-on-a-Chip’
11
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(LoaC) devices offer significant potential in biomedical and clinical anal-
ysis [5], in particular the ability to perform point-of-care measurements.
The term Lab-on-a-Chip can be used to encompass devices designed to
miniaturise analytical or bioanalytical techniques and integrate them into
a microfabricated format. BioMEMS, with a focus specifically on biological
applications can be considered a subset of Lab-on-a-Chip. Along with po-
tential device specific advantages, LoaC devices are typically advantageous
because they have:
 low fluid volumes consumption, because of the low internal chip vol-
umes
 higher analysis and control speed of the chip and better efficiency
due to short mixing times (short diffusion distances), fast heating
(short distances, high wall surface to fluid volume ratios, small heat
capacities).
 compactness of the systems, due to large integration of functionality
and small volumes.
 potential parallelisation due to compactness, which allows high through-
put analysis.
 lower fabrication costs, allowing cost-effective disposable chips, fabri-
cated in mass production.
 safer platform for chemical, radioactive or biological studies because
of low volumes.
12
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1.2.1 BioMEMS for Cell Based Analysis
Current State of the Art
MEMS technology has an inherent potential for providing the next genera-
tion of cell culture and cell analysis tools where large numbers of single cells
or small cell populations can be probed inexpensively, at high throughput,
and in a cellular microenvironment of increased physiological relevance with
respect to present cell culture methods [17].
There are a significant number of various MEMS based flow devices for
an ever increasing number of applications [18–24]. The two detailed below
are among the main types of devices used when considering cell oriented
MEMS devices under flow conditions.
Parallel Plate
A significant body of work has already been carried out in the area of shear
effects on biological species under flow conditions. [9, 25–28] The predom-
inant chamber design of choice has been the parallel plate flow chamber
(Figure 1.5). Following on from these parallel plate flow chamber trials,
efforts have been made to gain a deeper understanding of the impact of
the various design parameters. As a result, a large body of work has been
developed, investigating the implications of adjusting variables such as as-
pect ratio, entrance length and inlet design on overall performance of the
device. [29–31]
One of the advantages of the parallel plate flow chamber design is the
relative ease in which these parameter changes can be modelled from a fluid
behaviour point of view. The nature of the parallel plate flow chamber is
the low aspect ratio channel, where the width of the channel (w) is far in
excess of the height (h) (see Figure 1.5). The fact that the channel width is
so much larger than the channel height results in a significant simplification
13
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Figure 1.5: Parallel plate flow chamber schematic
of the governing equations and makes any calculations for shear relatively
simple. This will be dealt with further in Chapter 2.
Hydrodynamic Focusing
Another common device strategy for the manipulation of cells is termed hy-
drodynamic focusing. It exploits the fact that, due primarily to dimensional
constraints, flow in micro-devices is predominantly in the laminar regime
resulting in transfer of species based mainly on diffusion. This allows fluid
streams to be manipulated in non intuitive ways. [32–35] Standard hydro-
dynamic focusing is a technique whereby a central sample stream is shaped
and focused by a number of buffer streams with any mixing that may occur
being predominantly a function of the diffusivity of the media (Figure1.6).
In Figure 1.6 flow streams Q1 and Q3 serve to restrict the flow of sample
Q2. This restriction is such that sample stream Q2 is reduced to approxi-
mately the width of a single cell. The results in the cells of interest flowing
in single file through the sample stream. This allows individual cells be
interrogated (usually by optical means, in this case laser excitation coupled
with microscope detection) and statistically relevant information be ob-
14
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Figure 1.6: Principle of Hydrodynamic focussing
tained from a relatively small sample volume. By tuning relative flowrates,
one can control the width of the sample stream. Typically one sets Q1 = Q3
however these can also be manipulated independently to allow for stream
switching [36].
One of the most common uses for this technique is in flow cytometry.
Flow cytometry is a technique for measuring microscopic particles flowing
single file through a fluid medium. This technique can then interrogate
each particle separately. The technique is useful for counting cell or particle
populations or identifying sub-populations of particles. Hydrodynamic fo-
cusing is a method whereby this single file flow of particles can be relatively
easily achieved and characterised. In the last few years there have been a
marked increase in the number of these micro scale cytometers developed
and tested. [37, 38]
15
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1.3 Fabrication
A critical component in the development of Lab-on-a-Chip devices is the
ability to rapidly and reproducibly fabricate the structures required to ma-
nipulate fluids on the microscale level. While initial MEMS devices were
predominantly silicon based [39], advances in the field of microsystems cre-
ated the possibility of developing technologies for fabrication in other ma-
terials where silicon was unsuitable for a particular application. Among
the main disadvantages with using silicon for MEMS is its lack of optical
transparency.
The ability to microfabricate in an optically transparent medium creates
a plethora of opportunities for new applications of MEMS devices. Not least
of these is the area of BioMEMS where optically transparent substrates are
typically of significant importance for biological and chemical analysis, as it
facilitates the use of optical detection strategies and microscopy measure-
ments. As a result, initial BioMEMS devices were fabricated in glass as
many of the existing semiconductor techniques could be modified and ap-
plied to glass substrates. While this was advantageous from the perspective
of chemical and biological compatibility, mass production of this technology
on glass proved costly. Since a typical bio-sensor is often a single use, dis-
posable device, due to platform contamination by the biological or chemical
sample, there is a need for a method of producing multiple devices with a
short lead time and ultimately at low cost.
In the search for alternative materials, polymers have become the pop-
ular alternative for Bio-MEMS or Lab-on-a-Chip devices [40]. Polymers
offer several major advantages that are not immediately available in sili-
con or glass. These include a wide range of material characteristics, bio-
chemical compatibility, ease of processing and prototyping, and lower costs.
Broadly speaking, from a manufacturing perspective, polymer micro ma-
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chining strategies can be divided into two main sub groups; direct or repli-
cation techniques.
Figure 1.7: Direct machining techniques
Direct machining, as the name suggests, involves directly patterning a
surface, typically by material removal, to define a network of fluidic channels
of controlled depth and widths for a particular application. Typical polymer
direct machining techniques involve laser writing [41] or micro milling [42].
These techniques are extremely flexible and offer rapid turnaround and as
such are particularly suited to prototyping of MEMS devices.
Replication techniques, on the other hand, involve an additional, typi-
cally expensive, master fabrication step from all which all subsequent de-
vices are fabricated from. Replication strategies include injection mould-
ing [43], embossing [42] or die cutting techniques. Master fabrication strate-
gies may include using traditional machining techniques such as milling,
turning or spark erosion however silicon machining or photo lithographic
techniques may also be employed. The master fabrication step can vary
depending on the replication strategy used.
Typically however, this master fabrication step involves additional time
and cost for a single device. As such, replication techniques are typically not
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suitable for prototyping. However, since the cycle time per device for repli-
cation techniques is typically significantly shorter than direct techniques
replication techniques are more suited to pilot to mass production. The
Figure 1.8: Replication manufacturing schematic
techniques mentioned above are all well suited to planar fluidic devices.
However, use of laminate technologies has the propensity to rapidly develop
3D fluidic devices while also being compatible with mass production tech-
niques. Laminate technology involves the use of a thin polymer films of
various thicknesses with adhesive material on one or both sides. This adhe-
sive nature of the layer can be activated through pressure or in some cases
temperature. This pressure sensitive adhesive (psa) can then be patterned
and stacked in layers to created a 3D structure. Laminates also have the
advantages of being able to easily develop a hybrid chip where glass (used
for its biocompatibility) can be easily sealed to polymer used for its ease of
manufacture.
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1.3.1 Microsystems Fabrication Technologies
Current State of the Art
The development of microsystems for BioMEMS applications is an area of
intense research, especially when combined with the development of mi-
crofluidic systems. Polymer processing techniques have been widely ex-
ploited to this end and among the most commonly employed materials in a
laboratory setting is Polydimethlysiloxane (PDMS). Use of this elastomeric
polymer was pioneered by Whitesides [44] and has since been used for a
variety of applications from standard planar fluidic devices [45] to three
dimensional devices [46]. The elastomeric nature of the material also fa-
cilitates the development of microfluidics valves [47]. Lee et al [48] have
used PDMS for the development of micro lens arrays and pumps have been
described by Mathies and Dallas et al [49, 50].
Although PDMS fluidic networks have been used in commercial devices,
this remains the exception as thermoset polymers tend to be better suited
to mass production techniques. This is reflected in the literature; as the
development in Lab on a Chip devices moves from demonstration to utility
[17], there has been an increase in the number of publications describing
devices developed in thermoset polymers.
Hot embossing has been widely reported in a range of materials such as
polystyrene (PS), polyethylenetetraphthalate glycol(PETG), polymethyl-
methacrylate (PMMA), polyvinylchloride (PVC), polystyrene, and polycar-
bonate [51–55]. Instruments for automated hot embossing were developed
and sold commercially by Jenoptik Mikrotechnik GmbH in Germany.
Laser ablation was introduced in the literature as a method for fabri-
cating polymer microfluidic channels in 1997 by Roberts et al [56] and has
since been extensively used by Kutter et al [57, 58]. Ablation has been re-
ported in a range of materials such as PMMA, PETG, PVC, polycarbonate,
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polystyrene, and polyimide [51].
Injection moulding for microchannels was first described by Aclara Bio-
sciences and literature describing replication in PMMA [59], and polycar-
bonate [60, 61] has been published. Many commercial vendors of injection
moulded platforms, such as A˚mic or Gyros, utilise Compact Disc (CD)
injection moulding equipment as the feature sizes required for standard
CD replication are typically smaller than those required for microsystems
replication. Other groups [62] have utilised this CD format to exploit the
centrifugal forces generated on rotation to aid fluid delivery to the device.
Laminate techniques have been widely described by Micronics Inc and A-
line technologies [63–65] and have also been incorporated in NASAs GeneSat
program for the study of E.coli response in zero gravity [66].
1.4 Summary
Cardiovascular disease is a leading killer in developing countries. As a re-
sult platelet function research is currently a very active field of research.
However, many current commercial platelet function systems are limited
and many laboratory based systems are expensive, laborious and require a
high level of technical proficiency to operate. Current developments in the
field of micro electromechanical systems (MEMS), in particular BioMEMS,
has the potential to revolutionise platelet function analysis. The typical
BioMEMS characteristics of low sample volume consumption coupled with
high throughput analysis all at low cost opens up exciting prospects for
future platelet function devices. Fabrication of these devices however can
be challenging especially with the requirement of an economically viable
method for mass production. This has resulted in a significant body of
work being established in the area of polymer microfabrication, with ex-
isting conventional manufacturing techniques modified and new techniques
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developed in order to enable low cost fabrication of polymer MEMS devices.
1.5 Thesis Structure
Chapter 2 deals with the governing equations of fluidics with particular
emphasis on micro-scale effects. The chapter details these equations as
applied to rectangular microchannels and also introduces Computational
Fluid Dynamics as an important tool in the characterisation of micro fluidic
devices.
Chapter 3 discusses the available fabrication techniques and details the
merits of the chosen technique. An initial proof of concept device is detailed
from a design and manufacturing perspective.
Chapter 4 describes the experimental procedure for data extraction from
the fabricated device. In addition, the concept for an automated image
analysis is introduced the algorithm is developed and results are obtained
from the proof of concept device.
Chapter 5 introduces a revised device exploiting MEMS specific phe-
nomenon in order to improve throughput of the device. Furthermore, the
development of a miniaturised detection system incorporating thermal con-
trol, epifluorescense microscopy and fluid delivery is detailed.
Chapter 6 Outlines experimental data from the revised system and dis-
cusses any difference in results. Conclusions are drawn based on experimen-
tal as to the merits of both experimental systems.
Chapter 7 draws conclusions from the work reported here and highlights
possible future applications.
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1.6 Thesis Objectives
The objective of this project is to develop a point of care diagnostic tool
for early warning indication of platelet-related disorders. To this end, the
following are the specific objectives:
1. To design a robust platform to characterise platelet-surface interac-
tions in whole blood under vascular shear rates in response to VWF.
2. To develop an algorithm to objectively quantify platelet-surface inter-
actions in whole blood under physiologically relevant shear rates.
3. To utilise developments in the area of BioMEMS to significantly re-
duce the sample volume required for an experimental run.
4. To develop an integrated low cost miniaturised detection system, in-
corporating all fundamental aspects of existing laboratory detection
systems.
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Chapter 2
Theoretical Background and
Design Considerations
2.1 Introduction
From a fluid mechanics perspective matter consists of only two states, fluid
or solid. Although the difference between the two states may seem per-
fectly obvious, a rigorous definition of a fluid can prove difficult to formu-
late. While definitions such as ’a substance tending to flow or conform to
the outline of its container’ [1] gives us a sense of what a fluid is it does
not provide an appropriate technical description that can be applied in any
meaningful way. The technical difference between a fluid and a solid has
been defined by their response to shear (tangential) stress. A solid can re-
sist shear stress by a static deformation. A fluid cannot [2]. This definition
facilitates the application of principles of classical continuum mechanics to
determine if matter is fluid or solid. In order to further describe the mo-
tion of a fluid in response to these forces, Claude-Louis Navier and George
Gabriel Stokes developed a set of equations by applying Newtons second
law of motion to a body of fluid (See Appendix B). These equations are
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now known as the Navier-Stokes equations and are particularly useful in
describing a large number of fluid-based phenomena such as ocean currents,
stars in a galaxy and blood flow in capillaries. Since these equations are a
set of second order non-linear equations they can be computationally inten-
sive to solve and in many cases only approximate solutions can be obtained.
Many solution strategies have been enabled with the advent of the personal
computer and free and commercial software packages have been developed.
These packages have become collectively known as Computational Fluid
Dynamics (CFD) software and will be discussed further in section 2.5. In
the case of MEMS however, assumptions about the behaviour of the fluid
can be made so as to significantly simplify the governing equations. Fluid
flow in microsystems is predominantly laminar due primarily to the small
length scales of typical devices. This has the effect of removing the rota-
tional components of the Navier-Stokes equations and dictates that viscous
effects dominate over inertial effects thereby removing gravitational aspects
from many devices. In some special cases the Navier-Stokes equations can
be solved exactly and, with some further assumptions, these exact solutions
can be applied to describe fluid flow in micro-devices. In relation to blood
flow through micro devices, while whole blood is non-Newtonian in nature,
for the purposes of this work blood can be considered to behave as a New-
tonian fluid [3]. This can be justified when the shear thinning response of
whole blood is considered as shown in Figure 2.1.
As the shear rate increases a reorganisation of the red blood cells causes
a reduction in measured viscosity. This reorganisation has fully completed
before a shear rate of 100−1, after which viscosity of blood remains constant.
In the case of investigations into shear response in platelets, shear rates are
typically in the range of 1200 s−1 to 1800 s−1 [7] meaning for the purposes
of this work blood can be considered Newtonian fluid.
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Figure 2.1: Viscosity changes in whole blood in response to Shear
2.2 Steady Flow Between Parallel Plates
Depending on the technique used, fabrication of MEMS devices, can pro-
duce channels with various shapes of cross sectional areas. Silicon etching,
for example, results in a trapezoidal cross sectional profile while laser cut-
ting results in a characteristic ’U’ or ’V’ shape cross sectional profile. In
many cases however (e.g. milling, photolithography, laminate stacking),
the typical channel cross sectional area is rectangular in shape. Further,
in the case of shear force-related studies of platelet function, in response
to platelet activation agents under flow conditions, low aspect ratio rect-
angular channel profiles are widely used [4, 5]. This section describes the
governing equations of fluid mechanics in such parallel plate channels and
discusses the advantages of a low aspect ratio channel when studying shear
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force related platelet responses.
Consider a fluid of viscosity µ, flowing between two fixed, infinitely wide
parallel plates of length L, separated by a distance a as shown in Figure 2.2.
Assuming a constant pressure drop along the length L the Navier-Stokes
can be simplified to yield eqn 2.1.
Figure 2.2: Rectangular flowchamber notation
∂2u
∂z2
=
1
µ
dp
dx
(2.1)
Applying the following boundary conditions stating the velocity is zero
at both walls
u = 0 @ z = 0
u = 0 @ z = a
a solution for the velocity can be obtained in terms of channel geometry,
pressure drop and fluid viscosity.
u =
1
2µ
dp
dx
(z − a)z (2.2)
and the flow rate Q through a section of width w can be approximated
by
Q =
∫ b
0
dy
∫ a
0
1
2µ
dp
dx
(z − a)z dz = a
3b
12µ
dp
dx
(2.3)
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Since equation 2.2 is based on the assumption of infinitely wide parallel
plates, equation 2.3 is a highly aspect-ratio-dependent approximation of
volume flow rate and breaks down as the aspect ratio approaches 1. In the
case of an aspect ratio of one third, a = b/3, the error is as much as 23%
but falls to 7% for an aspect ratio of one tenth, a = b/10.
In spite of these discrepancies equation 2.3 is typically used to describe
the shear forces through parallel plate flow devices as typical aspect ratios
are on the order of one twentieth to one fiftieth. The main reason how-
ever, for utilising such low aspect ratio chambers is evident if the equation
describing two dimensional flow through a rectangular duct is plotted over
a range of aspect ratios as shown in Figure 2.3. As the aspect ratio in-
creases, the impact of the vertical wall on the flow profile decreases and
the flow can be assumed to become one dimensional across almost all the
chamber width, as described in equation 2.2. Coupled with a simplification
of the governing equations this type of chamber has practical implications
in terms of microscopy analysis. When imaging data from such a device,
the end user would not be required to position the platform, relative to the
microscope objective, with a large degree of accuracy in order to ensure a
consistent shear force over a number of experiments.
In order to calculate the wall shear force, τw, we use the shear force
equation
τw = µ
∣∣∣∣dudz
∣∣∣∣
z=0,z=a
=
a
2
dp
dx
(2.4)
For practical analysis, equations 2.3 and 2.4 can be combined to give
τw =
6µQ
a2b
(2.5)
which allows the calculation of wall shear force in terms of chamber
dimensions, fluid viscosity and volume flow rate.
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Figure 2.3: Velocity profiles through rectangular ducts of varying aspect
ratio.
2.3 Two phase flow
Two-phase flow is of significant importance in MEMS, where it is often
desirable to combine two liquids for further treatment, to perform chemical
analysis or to manipulate a sample fluid stream. In the case of microfluidics,
the characteristic of low Reynolds number systems means that mixing is
primarily a diffusive process allowing for unconventional manipulation of
fluid streams.
Consider the fixed infinitely wide parallel plates as previously described
in Section 2.2. In this case, however, consider the steady state flow of two
liquids between the plates under a constant pressure drop. The interface
between the two liquids is at a height h as shown in Figure 2.4.
The velocity profile can be described from two differentiable fields [6]
where
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Figure 2.4: Rectangular flow chamber notation
u =
{
u1 for 0 < z < h
u2 for h < z < a
(2.6)
In this case, the boundary conditions invoked are those of no wall slip as
in the case of the single fluid but also the additional conditions of continuous
velocity and shear stress at the interface z = h.
u1 = 0 @ z = 0
u2 = 0 @ z = a
u1 = u2 @ z = h
µ1
∂u1
∂z
= µ2
∂u2
∂z
@ z = h (2.7)
Applying these boundary conditions facilitates the solution
u1 =
1
2µ1
dp
dx
(h1 − z)z
u2 =
1
2µ2
dp
dx
(a− z)(z − h2) (2.8)
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where h1 and h2 are obtained from the last two boundary conditions and
are given by
h1 = a+ h2
h2 =
(
µ1
µ2 − 1)(1−
h
a )
µ1
µ2 (1−
h
a ) +
h
a
.h (2.9)
In a similar manner to the single phase system, the volume flow rate Q
across a width b can be approximated by
QTOT = Q1+Q2 =
∫ b
0
dy
∫ h
0
1
2µ1
dp
dx
(h1−z)zdz+
∫ b
0
dy
∫ a
h
1
2µ2
dp
dx
(a−z)(z−h2)dz
(2.10)
=
b
12
dp
dx
[
1
µ1
(
2h3 − 3h1h2
)
− 1
µ2
(
2h3 − (a+ h2)3h2 + (6a2 + h2a)h+ a3
)]
(2.11)
Equation 2.3 describes the volume flow rate through the chamber in
terms of the height of the fluid interface, the pressure drop along the length,
the chamber geometry and the fluid viscosities.
In this case, the shear stress at the walls must be calculated from the
piecewise differentials making up the velocity profile and are given by
τw(z=0) = µ1
∣∣∣∣du1dz
∣∣∣∣
z=0
=
h1
2
dp
dx
τw(z=a) = µ2
∣∣∣∣du2dz
∣∣∣∣
z=a
=
a+ h2
2
dp
dx
(2.12)
2.4 Forces on Platelets
While platelet-wall interactions have been shown to be highly dependent
on fluidic shear stress [7, 8] the mechanics of this dependence is not well
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understood. Further, once the platelet has contacted the activating surface
the forces involved in maintaining contact, causing translocation or adhe-
sion are largely fluid force independent. There has been some work carried
out in an effort to develop a greater understanding of the roles these forces
play in relation to thrombosis. Much of the literature, however, is based on
simplifications, based on non-physiologically relevant systems or on statis-
tically few platelets [9–11]. These simplifications result from the difficulties
in developing a greater understanding of what is an extremely complex and
dynamic system.
Figure 2.5: Rectangular flowchamber notation
Consider a single platelet, single receptor system as shown in Figure
2.5. The platelet motion can be characterised by a combination of physical
and biochemical interactions. The predominant physical force results from
fluid flow while, the imparted shear stress and torque affect the local and
global motion of the platelet near the surface. The platelet morphology and
deformability dictates how these externally applied forces are transmitted
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through or around the platelet. The biochemical interactions are primarily
receptor-ligand mediated. The factors affecting the biochemical forces are
the surface density and orientation of the ligand along the surface as well
as the surface density, number of receptors and receptor distribution over
the platelet surface. A key component of these ligand receptor interactions
are the binding rates and binding affinity. The binding affinity dictates the
strength of attraction of the receptor to the ligand surface while the binding
rates determines the speed of bond formation and dissociation. It should be
noted that these physical and biochemical forces are not mutually exclusive
and the net motion of the platelet as indicated in Figure 2.5 is a result of
both the physical and biochemical forces.
Even from the relatively simple single platelet single receptor situation
the complexity of developing a robust model depends on a number of well
defined paramteters. Coupling this with what is required to make a model
more physiologically relevant significantly adds to this complexity. When
considerations such as multi-platelet, multi-receptor systems are taken into
account the model changes dramatically as physical platelet-platelet in-
teractions must be taken into account, along with inter and intra cellular
signalling across multiple receptors. Taking these extra biochemical inter-
actions into account, using current computational techniques to develop a
robust model of these interactions, would prove extremely difficult, compu-
tationally extensive and cost prohibitive to develop since simulation times
would require a significantly longer time to prediction than current diag-
nostics require for time to result.
2.5 Computational Fluid Dynamics
While the development of a robust model for overall platelet function analy-
sis is unfeasible using current technologies, certain aspects of a platelet func-
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tion analysis may be modelled to give meaningful data for the design of next
generation devices. This is particularly true in the case of fluid modelling.
An understanding of how a fluid interacts with its surroundings can be of
significant benefit in the design of new technologies and techniques to study
platelet function, in particular, in the design of devices oriented towards
shear stress related response to an agonist under flow. While the governing
equations of fluid dynamics can be complex many software packages have
been developed to implement the algorithms, and numerical methods, re-
quired to solve fluid flow problems. Collectively these packages come under
the umbrella of Computational Fluid Dynamics (CFD) software.
CFD allows insight into flow patterns that may be difficult, expensive or
impossible to study using traditional, experimental techniques. It typically,
does not replace the measurements completely, more the amount of exper-
imentation. Further, the overall cost of development can be significantly
reduced, this is particularly true in the development of a new design.
While CFD can be a very useful tool it is important to remember that the
results of a CFD simulation are always a predicted measure based on user
defined assumptions of a system. Any discrepancy between the modelled
and experimental results may be due to
 the input data may relying inaccurate assumptions
 the mathematical model of the problem at hand being incomplete
 the accuracy of the results becoming limited by the available comput-
ing power
2.5.1 Application of CFD
Irrespective of the software vendor the application of CFD methods can be
characterised under three main headings.
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Pre-processing
The preprocessing stage of model development is typically the most labour
intensive and time consuming aspect of model development. In the prepro-
cessing stage the phyisical bounds of the model are defined, usually, in the
case of specialised software, by means of a graphical user interface. The
physical properties of the model are defined in terms of variables required
to solve the appropriate governing equations, for example a defined fluid
viscosity would be a prerequisite for the appropriate solution of the Navier
Stokes equations. Along with model physical bounds and properties, bound-
ary conditions of the model are also specified at the preprocessing stage.
The boundary conditions describe fluid behaviour and properties at de-
fined areas of the model. This leads to a general solution of the partial
differential equations for the specific model being developed. Knowing the
solution of the governing equations at certain specific points of the model
facilitates the ability to solve, or partially solve, the equations for the overall
model. See Section 2.3.
Another critical aspect of the preprocessing stage is the discretisation
or mesh generation strategy. This strategy determines how the modelled
area containing the continuous fluid is treated as distinct packets of space
by the processor to facilitate the solution through the entire model. The
most commons strategies are
 Finite Volume Analysis This strategy is most commonly used for
fluid mechanics problems and the involves calculating the fluid prop-
erty of interest at the centroid of each individual control volume de-
fined by the mesh size and interpolating across each control volume
to build up a solution.
 Finite Element Analysis This strategy calculates the fluid property
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of interest along the grid or mesh lines for each control volume and
builds up a representative image of fluid behaviour in this fashion.
 Finite Difference Analysis This strategy calculates the fluid prop-
erty at each node or intersection point of the mesh and based on
calculated values at the surrounding nodes interpolates the value at
the node of interest. Calculating a value for each node a representative
model of the entire system can be generated.
Simulation
During this stage of model development the computer processor solves the
equations based on the input from the preprocessing stage over based on
either a steady state or transient response. This stage of model development
is highly CPU intensive but requires little, if any, in the way of user input.
Post-processing
The post processing stage involves the analysis of the simulated solutions.
Typical software interfaces allow the visualisation of calculated parameters
such velocity profiles and pressure distribution while also allowing the user
to specify user defined quantities of interest.
2.5.2 Conclusion
The complicated nature of the governing equations of fluid mechanics was
outlined and detailed (See Appendix B). In the case of MEMS-based devices
it was seen that these equations could be simplified greatly to obtain exact
solutions for specific cases of geometries. These equations could then be
directly applied to practical cases of fluid flow through MEMS devices. In
addition the inherent complications of fully modelling a typical biological
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systems were described in terms of difficulties in both physical and bio-
chemical modelling. However, it was shown that while modelling an entire
system proves difficult there is value to be gained by modelling certain as-
pects of a device and the principles of computational fluid dynamics were
outlined along with its limitations and standard application procedure.
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Chapter 3
Fabrication Strategies and
Design
3.1 Introduction
Much of the current BioMEMS literature describes fabrication strategies
that, do not, in the main, lend themselves to mass production. The pre-
dominant material of choice for these prototype platforms is Polydimethyl-
siloxane (PDMS). While fabrication of microdevices using PDMS have been
commercialised these devices are typically encased in a more robust ther-
moset polymer. Thermoset polymer microdevices are typically more suit-
able for end use by untrained operators than PDMS devices and their physi-
cal robustness can offer additional advantages such as reproducible platform
to platform location on readout or detection systems. Among the main
advantages of PDMS however, is its flexibility in rapid prototyping new
designs. This makes PDMS an excellent research tool facilitating the abil-
ity to produce complex designs in relatively low numbers. However, while
there are rapid prototyping techniques available for thermoset polymers
there still remains a gap between techniques suitable for rapid prototyping
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and those suitable for pilot scale or mass production. This chapter looks
at the main techniques for microfabrication of thermoset polymer and pro-
poses a possible solution to the problem of transferring a device from proto-
type to mass production. This solution is then implemented into a parallel
plate flow chamber design as previously described. (Chapter 1 Section 1.2.1
). Furthermore, this design in then characterised using a computational
fluid model and coated with an known platelet activating agent (agonist)
in preparation for studies into platelet response.
3.2 Fabrication
3.2.1 Injection moulding
Injection molding as a technique for fabricating microchannels was first
described in literature by researchers at Aclara Biosciences [1]. A typical
injection moulding process involves the controlled heating of a plastification
chamber containing polymer pellets. See Figure 3.1
Figure 3.1: Injection Moulder Schematic [3]
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The chamber temperature is increased to a sufficiently high temperature
so as to melt the polymer pellets fed to the chamber via the hopper. This
’melt’ is then forced by the injection piston through the fixed platen via the
heated nozzle into a mould cavity and forced to flow over a master mould.
The mould typically consists of two metal plates, at least one of which has
been machined in order to form a defined cavity for replication of parts.
One half of the mould defining cavity is attached to the fixed platen while
the other is placed on a hydraulically actuated platen to facilitate mould
release.
On cooling of the melt, the polymer re-solidifies and takes the shape of
the negative of the master mould. The mobile platen retracts and the repli-
cated polymer part is ejected by means of hydraulically actuated hardened
steel pins contained within the mould cavity of the mobile platen. Once the
part has been released the mobile platen is re-mated with the fixed platen to
reform the mould cavity and the process is repeated. By adjusting the pro-
cess times and temperature, injection molded parts can be fabricated with
excellent precision. Injection molding has been used to reproducibly fabri-
cate plastic microfluidic channels in a range of polymers such as PMMA [1],
and polycarbonate [2, 4].
3.2.2 Embossing
Embossing or imprinting techniques for plastic microchannel fabrication
were first described in the late 1990s by several groups [5–8]. Some of the
initial methods described the use of wires for imprinting features in polymer
substrates [7]. Recently however, a silicon or metal micromachined stamp is
more commonly used as the imprinting tool for the fabrication of polymer
microfluidic devices.
To imprint or emboss microchannels, a silicon or metal stamp is placed
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on top of a hard polymer sheet. The stamp and polymer are then placed in
a hydraulic press and pressure is applied. Embossing is typically performed
at temperatures close to the softening temperature of the polymer and at
user defined forces of between 10-200 kN. Alternatively, polymer devices
can be imprinted at room temperature with elevated pressures. When de-
vices are hot embossed, the resulting plastic microchannel dimensions are
the exact mirror of the silicon stamp. When devices are imprinted at room
temperature however, the microchannel dimensions are much more depen-
dent on several parameters including imprinting pressure, imprinting time
and properties of the polymer itself [9].
Figure 3.2: Hot Embossing model HEX 02 from Jenoptik
Many common plastics have been successfully imprinted or hot embossed
with excellent device-to-device reproducibility. These include polystyrene
(PS), polyethylenetetraphthalate glycol(PETG), polymethyl-methacrylate
(PMMA), polyvinylchloride (PVC), polystyrene, and polycarbonate [10–
14]. Although many research groups have developed in-house embossing
instruments. Commercial systems for automated hot embossing were devel-
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oped and sold commercially by Jenoptik Mikrotechnik GmbH in Germany.
See Figure 3.2
3.2.3 Laser processing
Laser ablation was introduced in the literature, in the early nineties, as a
method for fabricating polymer microfluidic channels by Roberts et al. [15].
In the photoablation process, a polymer is exposed to a pulsed Ultra
Violet (UV) laser source, and the absorption of that light energy causes
the molecular bonds of the polymer backbone to break resulting in the
removal of a layer of polymer from the surface [16]. Excimer lasers with
emissions of 193 nm (ArF) or 248 nm (KrF) are both effective in polymer
ablation but to varying degrees depending on the absorption spectra of
the polymer. Polymers that have significant absorption at the emission
wavelength of the laser are the most effectively ablated. In contrast to the
UV laser, a CO2-laser emits infrared radiation at a wavelength of 10.6 µm.
This means that the CO2-laser beam always ablates the underlying material
photothermally [17]. This leads to a broader range of machinable polymers
for CO2-laser systems but also a large variation in feature quality obtainable
from such systems.
Ablation processes can be mask based or direct write systems (See Figure
3.3). In the case of mask based systems, the mask is made from a material
that does not have significant absorption at the laser wavelength, e.g. some
metals. For a direct write system, the polymer substrate material is placed
on a moveable, typically programmable, stage, and the substrate is moved
under the focused laser beam to create the desired structure. The laser beam
may be further defined by passing it through an aperture of appropriate
dimension and shape prior to focusing. The direct-write micromachining
process is advantageous in that a mask does not have to be created to
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Figure 3.3: Direct and Mask based Laser Ablation processes
change the design of the microchannel network; therefore, channel design
can be changed rapidly during the prototyping process. The disadvantage
to this approach is that parts are made in a sequential manner thereby
limiting the ability to mass produce devices for commercial applications.
3.2.4 CNC Micro milling
Computer Numerically Controlled (CNC) milling is a direct machining pro-
cess based on physical material removal from a substrate facilitated by a
rotary cutter spinning about an axis. The cutter is brought into contact
with the material to be machined via computer controlled stepper motors
and in contrast to the standard drilling process the milling cutter can be
moved laterally relative to the workpiece, also via computer controlled step-
per motors. This lateral motion along whats known as the cutter tool path
results in a profile of the milling tool being cut from the workpiece mate-
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rial. Using multiple defined tool paths, typically generated by means of a
computer aided design package, the milling process has the capability to
machine complex structures in a broad range of materials.
The ability to fabricate in a broad range of materials makes the mi-
cromilling process a very attractive option for both rapid prototyping and
mass production capabilities. During the prototyping phase a range of de-
vices can be designed and tested by machining directly into a chosen poly-
mer. Once the design has been finalised the negative of this design can
then be machined into an alternative material suitable for further use as a
replication tool in any one of the processes mentioned in Sections 3.2.1 and
3.2.2.
3.2.5 Laminates
Although not strictly a fabrication technique, the use of laminates, in a
unique way, facilitates the fabrication of MEMS devices and are suited to
rapid prototyping and mass production methodologies coupled with some
additional advantages making them a very attractive option for the devel-
opment of platforms to investigate platelet function in response to shear
stress.
Many of these laminate films are manufactured with extremely tight
thickness tolerances and are available with an increasing number of op-
tions; porous, conductive, foil backed, dissolvable and drug eluting films are
all currently available as either commercial or research grade and can be
supplied over a range of thicknesses from 10 - 200 µm. Standard lami-
nates are commercially available with heat or pressure activated adhesive
on one or both sides making them extremely useful for sealing micro de-
vices. Among the more technical issues with the development of thermoset
microfluidic platforms is the ability to seal the fluidic channels in order
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to form a closed flow chamber. While many groups have provided labo-
ratory specific solutions for specific grades of polymers [18, 19] this does
not provide a generic solution to what can be a significant technical chal-
lenge. Furthermore, many existing techniques require elevated temperature
to ensure sufficient bonding between the parts and this can lead to channel
ingress and deformation along the flow cavity [20]. Use of single or double
sided pressure sensitive adhesive (psa) laminate layers facilitates a rapid
solution to sealing microdevices on a range of polymers, and other MEMS
materials, where the wall material properties are not of critical concern.
While sealing existing microfluidics devices is of obvious benefit these
laminate films, in particular psa, can be further utilised if the film itself
is patterned. This results in the laminate layer defining the flow chamber
and the height tolerance defined by the thickness of the laminate. The
width tolerances are defined by the patterning process but are generally
not as tight as the height tolerances due to both the patterning process and
the effects of the adhesive ingressing into the channel. The level of ingress
into the channel is laminate specific and a function of the adhesive material
itself, the adhesive layer thickness, the sealing temperature and the pressure
applied.
(a)Laser Cut (b)Die Cut
Figure 3.4: PSA Cut Quality
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Although width tolerances of 10µm have been reported [21] this toler-
ance is highly production technique specific. Patterning laminates using
a CO2 laser is very useful when developing initial prototypes due to its
flexibility however the photothermal ablation process causes relatively large
thermal distortion and can cause considerable, although relatively repro-
ducible, edge ooze effects. See Figure 3.4 (a). For mass production however
a rotary tool and die configuration results in excellent edge quality, minimal
edge ooze and an extremely rapid method of patterning laminate films. See
Figure 3.4 (b). These patterning or conversion techniques are commercially
well established developed initially for the labelling industry, where large
scale reproducible patterning of adhesive labels is common practice.
3.2.6 Summary
Feature Materials Prototyping Mass Multi
Sizes Production Layer
Inj. Moulding sub µm Polymers/ No Yes Difficult
Composites
Hot Embossing sub µm Polymer Yes No No
Milling 10s µm Polymers/ Yes No Difficult
Metals
Laser sub µm Polymers Yes Yes No
Laminates 10s µm Polymers/ Yes Yes Yes
Metals
Table 3.1: Table comparing fabrication techniques.
Table 3.1 summarises the aforementioned fabrication techniques with
a view to choosing an appropriate technique for a given application. The
table is by no means a comprehensive overview of available techniques but
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should serve as a guide in the decision making process. Each technique may
have device specific advantages or disadvantages promoting or inhibiting
the technique as suitable or unsuitable for a given application.
3.3 Platform Design
One of the primary objectives of this work was to develop a robust plat-
form to objectively characterise shear-force dependent platelet-surface in-
teractions in whole blood. To this end, the chamber type was chosen to
be of parallel plate type design due to, its simplification of the governing
equations and practicality of use. Further, a fabrication technique was re-
quired that was both flexible in terms of testing alternative designs and also
facilitated a smooth transition from a prototype development phase to the
pilot scale production required for more rigorous testing of numerous blood
samples. It was for this reason primarily, that the use of laminates was the
chosen fabrication methodology. Use of laminates however, are not without
other advantages in the development of a parallel plate platform. These
include:
 The very tight thickness tolerance of commercial laminates is ex-
tremely useful when the laminate layer itself is patterned to define
the flow channel. Since the flow channel was chosen to be paral-
lel plate in nature the channel height has a significant impact on the
shear stress generated (see Chapter 2 Section 2.2). Using the laminate
to define the flow area significantly reduces the possibility of platform
to platform height variations, particularly in the prototyping/batch
production stage of development.
 Adhesive based laminates facilitate sealing of microfluidic devices and
this is of importance when defining channel cross sectional area. It
57
CHAPTER 3. FABRICATION STRATEGIES AND DESIGN N.J.Kent
is the flexibility of sealing provided by adhesive laminates that is ex-
tremely advantageous. While various sealing techniques are available
in the literature these can be labour intensive and typically limited
to sealing two or more substrates of the same polymer and of similar
thickness. Use of laminates eliminates these issues and facilitates rel-
atively simple bonding of different materials over a range of material
thicknesses.
Figure 3.5: Single inlet single outlet platelet function device
In terms of platform design, the initial platform consists of a three layer
design as shown in Figure 3.5. The top plate was chosen to be Polymethyl-
methacrylate (PMMA). PMMA is among the more common materials used
in polymer MEMS production, due to its high optical transmission and rela-
tive ease of machining making it useful for injection moulding or alternative
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replication techniques. For top plate manufacture, 6mm thick PMMA stock
was milled to dimensions of 75mm long and 25mm wide corresponding to
a standard microscope slide. This piece was then drilled and tapped to
facilitate the required inlet and outlet connection ports as shown in Figure
3.5 a.
The middle layer material, defining the flow path, was chosen to be
a commercially available double sided laminate from Adhesives Research.
ArCARE8890 is a 12.5 µm polyester film coated on both sides with an
acrylic medical grade adhesive resulting in an overall thickness of 50 µm.
For ease of transportation and handling the film is protected on both sides
with a 50 µm thick polyester release liner as shown in Figure 3.6.
The flow path layer was manufactured using a Coherent GEM-100TM
liquid cooled CO2 laser embedded in a Micromaster Turnkey dual head laser
system. The flow path design is drawn in AutoCAD and imported to the
machine in R14.dxf format. The laser software then translates the drawing
to machine readable code translating the computer drawing to a functional
part of the overall design. As with the top-plate the outer dimensions of the
laminate or gasket layer corresponds to microscope slide dimensions. This
facilitates the ease of use of the platform in existing commercial detection
systems for validation purposes. The length of the flow channel is 50 mm.
This length ensures ease of access to the inlet and outlet ports of the plat-
form when the platform is positioned within the existing detection system.
The flow chamber height is determined by the laminate height i.e. 50 µm
while the width was laser patterned to a width of 2mm. The width of 2mm
was chosen so as to ensure relative ease of alignment of the platform over
the detection area of the readout system. This 2mm channel width results
in a flow channel aspect ratio of 0.025 (1:40) and a cross sectional area of
100 x 10−9 m2 compared to the cross sectional area of 1.27 x 10−6 m2 for
the existing commercial parallel platform. In practical terms, this results
59
CHAPTER 3. FABRICATION STRATEGIES AND DESIGN N.J.Kent
in a reduction of the volume flowrate required to generate a physiologically
relevant shear stress of 6N/m2 from 2.41 mL/min to 0.075 mL/min. This
reduction corresponds to approximately a 97% reduction in required volume
flowrate.
Figure 3.6: ArCARE8890
As the flow path is a critical aspect of the design, this fabricated layer
was characterised (see Figure 3.7) using white-light interferometry tech-
niques using a WYKO NT100 from Veeco. The height of the PSA measures
48.5 µm (material thickness specification: 50 µm), while the overall width
of the flow path, 2.10 mm, is within 5% of the 2.0 mm design target. The
sidewall roughness associated with the manufacturing process and adhesive
ingress into the channel, was viewed empirically using brightfield microscopy
and the maximum ingress was seen to be 35 µm for a series of 10 measure-
ments made along the channel sidewall (5 measurements per sidewall). This
ingress can be deemed insignificant to the operation of the device due to
the geometry and very low aspect ratio (1:40) of the flow path. The mea-
sured dimensions for flow path height and width, compared to the design
dimensions, imply a difference of wall shear force of just over 1% relative to
design.
The base layer of the platform is a commercially available glass micro-
scope coverslip, chosen for three reasons:
 The majority of standard protein deposition techniques are already
well established on glass surfaces. Further, many protein layer char-
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Figure 3.7: Dimensional characterization of fabricated microfluidic parallel-
plate device using white-light interferometry
acterisation techniques have also been developed based on glass sur-
faces.
 The thickness and refractive index of the slides are compatible with
existing oil immersion lens for optical detection of platelet surface
interactions.
 High quality glass coverslips are a widely available commodity with
tightly controlled dimensional, optical, and surface-finish tolerances,
in addition to having predictable and reliable surface chemistry.
To assemble the device, the glass cover slip was placed in a custom
machined alignment jig, the release liner removed from the psa layer, and
aligned over the glass cover slip. The remaining release liner was then
removed from the psa layer, and the PMMA plate aligned over the top of
the exposed psa layer. The entire fixture was then removed and pressed
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together through two rollers to form a sealed device (see Figure 3.5 (c)). In
order for the sealed device to be employed as a platelet function analysis
platform both glass coverslip and machined top plate are passed through a
cleaning protocol involving a wash step with absolute ethanol which is then
allowed to evaporate prior to chamber assembly and rinsing by perfusion
with aqueous buffer (PBS) post assembly. Further, a computational fluid
dynamic (CFD) model was developed to validate shear stress predictions.
Also the internal surfaces were coated with VonWillebrand Factor, a protein
prevalent in initial adhesion of platelets on the site of vascular injury.
3.3.1 CFD Analysis
While the equations governing laminar flow of a single phase medium,
through a rectilinear channel are relatively simple, the development of a
CFD model allows a rapid way to visualise the effect of changing boundary
conditions, fluid properties or flow conditions. To this end a CFD model of
the platform as described in Section 3.3 was developed. While the device
itself is relatively straight forward, there are some modifications which can
be made to make the model more efficient. This efficiency can be trans-
lated into either a reduction in post processing time for the model or as
increased resolution of results depending on the type of analysis required.
The simplification for this particular model is based around symmetry of
the governing equations for flow through a rectilinear channel.
As seen in Figure 3.8 the velocity profiles can be considered symmetrical
about the horizontal and vertical planes through the centre of the channel.
This symmetry results in a significant simplification of the model as only a
single quadrant of the device requires modelling in order to give meaningful
data for the overall device. This resulted in a significantly shorter post
processing time and allows for more rapid analysis of the device behaviour.
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Figure 3.8: Modelled Simplification of Flow Device
A 3-D model of the lower right quadrant of the platform, as shown in
Figure 3.8 was generated using CFD-GEOM. CFD-GEOM is the pre pro-
cessing component of CFD ACE+, a commercially available multi physics
package available from ESI Software. This modelling package was used to
model fluid flow throughout this body of work unless otherwise stated. Ap-
plying the symmetrical simplifications the model cross sectional area was
1mm wide and 25 µm high. The channel length was arbitrarily chosen to
be 20mm in length as the velocity profile is independent of distance along
the channel based on the an assumption of steady state flow through the
device. Since the model was relatively simple, a homogeneously distributed,
structured mesh was generated containing a total 34,029 cells.
For the simulation phase blood was modelled as a continuum fluid with
a density (ρ) of 997kg/m3 and a dynamic viscosity (µ) of 0.004Pa.s. The
symmetrical boundary conditions, as described, were imposed on the ge-
ometry and the mass flow rate through the device was determined to be
3.115x10−7kg/s This value was found using equations describing volume
flow rate detailed in Chapter 2 and also taking into account the symmet-
rical boundary conditions and based on a wall shear stress of 6N/m2 rep-
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resentative of a typical vascular shear stress. The default solver for CFD
ACE+ utilises the finite volume method as described in Chapter 2 Section
2.5.1 and running the model under these conditions resulted in a model
convergence after 57 iterations with a run time of 64 secs.
Results
The graphical results from the analysis can be seen in Figures 3.9 and 3.10.
Both figures show a perspective view of the modelled channel quadrant with
a section cut through the channel as indicated, and flow direction indicated
by a velocity vector field (blue arrows). Each section cut is colour coded;
based on Velocity in the case of Figure 3.9 and Shear Rate in the case of
Figure 3.10. The inset graph on each figure shows a plot of the specified
property as a function of the channel height taken along the mid point of
the channel. It should be noted that the inset graphs are representative of a
single quadrant of the flow channel, as indicated in Figure 3.8, and as such
the graphs shown in Figure 3.9 and Figure 3.10 are representative of the
velocity and shear rate, respectively, within a single quadrant of the flow
chamber.
Figure 3.9 shows the classic parabolic velocity flow profile, as expected,
and returns a calculated maximum velocity of 0.01898m/s.
Figure 3.10 shows the generated shear rate in the channel based on a
blood viscosity of 0.004Pa.s The modelled wall shear rate is shown to be
1498s−1 which is in close agreement with the calculated value of 1500s−1
using equations developed in Chapter 2
Other points to note from both figures is the effect of the low aspect
ratio channel. In particular, in the case of Figure 3.10 it can be seen the
maximum shear rate, indicated in red along the ’Section Cut’, occurs at the
wall of the channel and is almost constant across the entire width of the
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Figure 3.9: CFD Velocity Profiles
Figure 3.10: CFD Shear Rate Results
channel. As previously described, this has practical implications when it
comes to using the platform for shear stress mediated response of platelet
function as it largely eliminates the requirement for accurate alignment of
the device over the imaging optics of a detection system.
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3.3.2 Chemistry Deposition
In order to develop a platform for successful characterisation of platelet
function in response to various agonists, coupled with the a well defined
and characterised platform is the requirement for a well defined and char-
acterised activating surface. While there are a number of strategies for
immobilising biological species onto surfaces among the simplest is termed
physisorption. Physisorption at its simplest is allowing a solution contain-
ing a known concentration of the biological species of interest sit on the
substrate, onto which immobilisation is to occur, for a period of thirty min-
utes to two hours. The attraction is caused by inter-molecular, van der
Waals forces between the species and the substrate of interest. While this
immobilisation strategy is among the simplest to implement it can be sus-
ceptible to errors in reproducibility due to the relatively weak van der Waals
attractive forces.
In order to investigate the surface coverage and density of Von Wille-
brand Factor (VWF) through physisorption two characterisation techniques
were employed. The simpler of these techniques involves fluorescent staining
of immobilised VWF over a range of concentrations. Four glass cover slips
were coated with different concentrations of VWF ranging from 1ug/ml
to 100ug/ml for two hours. The slides were then washed with Phosphate
Buffer Solution (PBS). The slides were then coated with a Fluorescein isoth-
iocyanate (FITC) labelled antibody against von Willebrand Factor for 15
minutes and subsequently washed using PBS. These slides were then im-
aged under a Zeiss LSM-510 Meta laser scanning confocal microscope and
results are shown in Figure 3.11
While not quantitative, the data shows a clear increase in fluorescent sig-
nal with increasing concentrations of Von Willebrand Factor. This suggests
that physisorbtion is a suitable method for immobilising VWF on a glass
66
CHAPTER 3. FABRICATION STRATEGIES AND DESIGN N.J.Kent
(100µg/mL) (50µg/mL)
(20µg/mL) (1µg/mL)
Figure 3.11: Various concentrations of immobilised VWF
surface. In order to acquire more quantitative data however, a technique
known as ellipsometry was employed. Ellipsometry is an optical technique
that, in its most basic configuration, exploits changes in phase and polari-
sation of reflected or transmitted light from or through a substrate. Sample
properties such as refractive index or film thickness causes a phase shift
and changes the polarisation state of the incident light. The ability to mea-
sure and characterise these changes allows the user to determine specific
information, such as film thickness, from the film of interest.
In the case of characterising Von Willebrand Factor coatings of vari-
ous concentrations of VWF in solution were deposited on a silicon wafer
in a similar manner as the previously described on glass. Since reflection
ellipsometry was being employed, silicon was deemed to be a more suit-
able surface for characterisation as internal reflections from glass substrates
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Figure 3.12: Ellipsometry data of von Willebrand Factor on Silicon
could potentially influence results. Since silicon and glass have similar ma-
terial properties the van der Waals attractive forces were considered to be
of a similar magnitude resulting in comparable film thickness on both glass
and silicon for a given concentration of Von Willebrand Factor. The VWF
solutions were deposited on silicon, left to sit for two hours, and excess
VWF subsequently washed off using a combination of PBS and deionised
water. Each sample was then interrogated in five individual locations, in
an effort to determine coating homogeneity, using a UVISEL Spectroscopic
Ellipsometer from Horiba Jobin Yvon and the results can be seen in Figure
3.12.
It should be noted that ellipsometric film thickness measurements are
effective thickness measurements, measured over an interrogation spot size.
In the case of relatively low protein concentrations, e.g. 20µg/mL as shown
in Figure 3.11, ellipsometric measurements are a representation of both
occupied and unoccupied protein locations and should not be confused with
68
CHAPTER 3. FABRICATION STRATEGIES AND DESIGN N.J.Kent
homogeneous protein coverage over the entire surface.
Nonetheless the results show an increase in effective protein coating
thickness with increasing concentration as expected. The saturation point
occurs at a concentration point of approximately 500µg/mL and coating
thickness of approximately 3nm. The inset graph shows the reproducibility
of the deposition technique for a single concentration of 100µg/mL over four
individual samples. As in the previous experiment each of these samples
were individually interrogated five times at different locations in an effort to
characterise coating homogeneity. Overall, from both sets of experiments,
the results clearly show phisisorbtion to be a reproducible and character-
isable method for controlled deposition of Von Willebrand Factor on glass
surfaces.
3.4 Conclusion
This chapter has detailed the main prototyping and replication techniques
for thermoset polymers used in the area of BioMEMS fabrication. While
some techniques are particularly suitable for rapid prototyping bridging the
gap between this initial phase and pilot to mass production can be difficult
as the master tools required for many replication techniques are often cost
prohibitive. Manufacturing using thin film laminates was offered as a rela-
tively new alternative to the problem of bridging this apparent gap as the
patterning techniques for these films lend them selves well to prototyping
technologies ,in terms of laser cutting, and mass production techniques, in
terms of rotary tool and die configurations routinely used in the labelling
industry. The availability of various configurations of these laminates was
also highlighted in terms of offering other potential advantages for BioMEMs
device development such as the adhesive nature of the many laminates fa-
cilitating the ability to rapidly seal devices and easily create multi-material,
69
CHAPTER 3. FABRICATION STRATEGIES AND DESIGN N.J.Kent
multi-layer hybrid devices.
Using the already described laminate technologies, the design and build
of a platelet function analysis device for shear mediated response in the
presence of an agonist was detailed. The device exploits the tight thickness
tolerances of the laminate adhesive, the ability to rapidly create hybrid
polymer-glass devices and the low aspect ratio of the device builds on the
flow theory as developed in Chapter 2.
A computational fluid model of the device was generated using a com-
mercial fluid simulation software package known as CFD ACE+. This fa-
cilitated the ability to study the predicted effects of changing boundary
conditions and fluid properties of the device with particular emphasis on
how these changes impacted on the shear stress profile generated within the
device. In order to finalise the prototype for initial testing a strategy of
immobilising an activating protein on a surface was described. This strat-
egy, among the simpler of the available techniques relies on the molecular
attractions between the glass wall of the device and the protein in question,
in this case Von Willebrand Factor. This strategy was then validated using
fluorescence labelling of the Von Willebrand Factor imaged under a confo-
cal microscope and further characterised in terms of protein concentration
versus coating thickness, coating homogeneity over a single coated glass
slide and coating reproducibilty from glass slide to glass slide. In short,
the designed device for investigations into shear mediated platelet response
to Von Willebrand Factor was built, characterised and made available for
initial testing.
70
Bibliography
[1] R.M. McCormick, R.J. Nelson, M.G. Alonso-Amigo, D.J. Benvegnu,
and H.H. Hooper. Microchannel electrophoretic separations of DNA
in injection-molded plastic substrates. Anal. Chem, 69(14):2626–2630,
1997.
[2] A. van den Berg, W. Olthuis, and P. Bergveld. Micro Total Analysis
Systems 2000: Proceedings of the [Mu] Tas 2000 Symposium, Held in
Enschede, the Netherlands, 14-18 May 2000. Kluwer Academic Pub-
lishers, 2000.
[3] Babyplast 6/10 Instruction Manual Chronoplast S.L. Barcelona.
[4] G.J. Kellogg, T.E. Arnoldt, B.L. Carvalho, D.C. Dulfy, and N.F. Shep-
pard Jr. Centrifugal Microfluidics: Applications. Micro Total Analysis
Systems 2000: Proceedings of the [Mu] Tas 2000 Symposium, Held in
Enschede, the Netherlands, 14-18 May 2000, 2000.
[5] L. Lin, C.J. Chiu, W. Bache, and M. Heckele. Microfabrication using
silicon mold inserts and hot embossing. Micro Machine and Human
Science, 1996., Proceedings of the Seventh International Symposium,
pages 67–71, 1996.
71
BIBLIOGRAPHY N.J.Kent
[6] H. Becker, W. Dietz, P. Dannberg, and G. Jena. MICROFLUIDIC
MANIFOLDS BY POLYMER HOT EMBOSSING FOR µTAS AP-
PLICATIONS. Micro Total Analysis Systems’ 98: Proceedings of the
[Mu] TAS’98 Workshop, Held in Banff, Canada, 13-16 October 1998,
1998.
[7] L. Martynova, L.E. Locascio, M. Gaitan, G.W. Kramer, R.G. Chris-
tensen, and W.A. MacCrehan. Fabrication of Plastic Microfluid Chan-
nels by Imprinting Methods. Burns, 144:147.
[8] L. Locasci&, M. Gaitan, J. Hong, and M. Eldefrawi. PLASTIC MI-
CROFLUID DEVICES FOR CLINICAL MEASUREMENTS. Micro
Total Analysis Systems’ 98: Proceedings of the [Mu] TAS’98 Workshop,
Held in Banff, Canada, 13-16 October 1998, 1998.
[9] J. Xu, L. Locascio, M. Gaitan, and C.S. Lee. Room-Temperature
Imprinting Method for Plastic Microchannel Fabrication. Science,
261:895, 1993.
[10] T.J. Johnson, E.A. Waddell, G.W. Kramer, and L.E. Locascio. Chem-
ical mapping of hot-embossed and UV-laser-ablated microchannels
in poly (methyl methacrylate) using carboxylate specific fluorescent
probes. Applied Surface Science, 181(1-2):149–159, 2001.
[11] H. Becker and U. Heim. Hot embossing as a method for the fabrica-
tion of polymer high aspect ratio structures. Sensors & Actuators: A.
Physical, 83(1-3):130–135, 2000.
[12] K. Ueno, F. Kitagawa, H.B. Kim, T. Tokunaga, S. Matsuo, H. Misawa,
and N. Kitamura. Fabrication and Characteristic Responses of Inte-
grated Microelectrodes in Polymer Channel Chip. Chemistry Letters,
29(8):858–859, 2000.
72
BIBLIOGRAPHY N.J.Kent
[13] K. UCHIYAMA, W. XU, M. YAMAMOTO, T. SHIMOSAKA, and
T. HOBO. Development of Imprinted Polymer Microchannel Capil-
lary Chip for Capillary Electrochromatography. Analytical Sciences,
15(9):825–826, 1999.
[14] SA Soper, SM Ford, S. Qi, RL McCarley, K. Kelly, and MC Murphy.
Polymeric microelectromechanical systems. Anal Chem, 72(19):642A–
651A, 2000.
[15] M.A. Roberts, J.S. Rossier, P. Bercier, and H. Girault. UV Laser
Machined Polymer Substrates for the Development of Microdiagnostic
Systems. Science, 261:895–897, 1993.
[16] S. Lazare and R. Srinivasan. Surface properties of poly (ethylene
terephthalate) films modified by far-ultraviolet radiation at 193nm
(laser) and 185nm (low intensity). The Journal of Physical Chemistry,
90(10):2124–2131, 1986.
[17] M. Bowden, O. Geschke, J.P. Kutter, and D. Diamond. CO2 laser
microfabrication of an integrated microfluidic manifold for application
in environmental monitoring. Lab-on-a-Chip, 3(4):221–223, 2003.
[18] L. Brown, T. Koerner, J.H. Horton, and R.D. Oleschuk. Fabrica-
tion and characterization of poly (methylmethacrylate) microfluidic
devices bonded using surface modifications and solvents. Lab on a
Chip, 6(1):66–73, 2006.
[19] J. Li, D. Chen, and G. Chen. Low-Temperature Thermal Bonding of
PMMA Microfluidic Chips. Analytical Letters, 38(7):1127–1136, 2005.
[20] E´. Tyrrell, C. Gibson, B.D. MacCraith, D. Gray, P. Byrne, N. Kent,
C. Burke, and B. Paull. Development of a micro-fluidic manifold for
73
BIBLIOGRAPHY N.J.Kent
copper monitoring utilising chemiluminescence detection. Lab on a
Chip, 4(4):384–390, 2004.
[21] B.H. Weigl, R. Bardell, T. Schulte, F. Battrell, and J. Hayenga. De-
sign and Rapid Prototyping of Thin-Film Laminate-Based Microfluidic
Devices. Biomedical Microdevices, 3(4):267–274, 2001.
74
Chapter 4
Results and Analysis
4.1 Introduction
Following design, fabrication and characterisation of the parallel plate plat-
form, the next stage in the development of the device, was to apply real
world samples in order to validate the efficacy of the new design. To this
end, a dual approach was taken. For the newly designed parallel plate
device to be considered successful, it must first be seen to function in a
comparable manner to existing commercial devices i.e. cell surface interac-
tions must take place. Further, however, in order to be deemed a successful
working prototype, the device must demonstrate the ability to function as
a diagnostic indicator in its own right.To this end two sets of experiments
were devised.
To validate the device itself, minimally treated, whole blood was passed
through both the commercial parallel plate flow device and the newly de-
signed device and the resulting interactions were imaged using fluorescent
microscopy.
To investigate the diagnostic potential of the device, minimally treated
whole human blood was compared to whole blood to which an integrin-
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blocking c7E3-Fab fragment, known as Abciximab, was added. This c7E3-
Fab fragment inhibits the receptor αIIbβ3 on the platelet surface. This
inhibition has a dual effect preventing both, stable adhesion to VWF, as
well as inhibiting fibrinogen-mediated platelet-platelet binding. Abciximab,
distributed under the trade name ReoPro, is commonly used in individuals
undergoing angioplasty with or without stent placement. Use of ReoPro
in this setting is associated with a reduction in procedural-related ischemic
complications [1]. Side effects however, can include gastrointestinal hemor-
rhage [2] or in rare cases thrombocytopenia [3]. While ReoPro can be seen
to take effect in under ten minutes, its effects on platelet function are evi-
dent after 48 hours and low level Gp αIIbβ3 inhibition can be present for up
to 15 days. In short, utilising ReoPro to characterise the efficacy of the new
chip, provides an ideal test platform for the device. ReoPro sales exceeded
the 380 million dollar mark in 2007, and a device offering rapid results on
the efficacy of the drug in an individual would be of obvious benefit.
Among the more attractive options with using ReoPro as a test case for
the device was the ability to carry out multi-parameter testing. Since Reo-
Pro inhibits both stable adhesion of platelets on VWF and also fibrinogen-
mediated platelet-platelet binding, this allowed for a dual analysis approach
focussing on each interaction independently. In order to measure variations
in these interactions, customised image analysis software was developed.
The software was developed specifically to evaluate:
 Changes in surface coverage over time, characterising the inhibition
of αIIbβ3 on stable platelet adhesion to VWF.
 Platelet cluster analysis after a predefined length of time, characteris-
ing the inhibition of fibrinogen-mediated platelet-platelet aggregation.
Specifics of the software analysis strategy are further detailed in Section
4.3.1.
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4.2 Experimental Procedure
The experimental configuration used to test the parallel plate device is
shown in Figure 4.1. The experimental setup consists of a Zeiss Axiovert-
200 epi-fluorescence microscope (Carl Zeiss Light Microscopy, Germany)
used for imaging platelet surface interactions under flowing conditions, a
Harvard PhD 2000 (Harvard Apparatus) syringe pump for sample delivery
to the parallel plate flow device, a temperature-controlled chamber to main-
tain the device at 37o C (controller from Prior Electronics), and a liquid-
cooled Quantix-57 CCD camera (Photometrics Ltd, Tuscon, AZ, USA) that
records platelet adhesion events and saves them to a PC for subsequent
analysis.
Figure 4.1: Experimental Setup
Prior to experimental runs, the channels of assembled platelet function
devices were coated with Von Willebrand Factor at a concentrations of
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100µg/mL in Phosphate Buffer Solution (PBS). The flow chamber was in-
cubated for two hours at room temperature and subsequently blocked using
a 1% Bovine Serum Albumin (BSA) solution for one hour. The chamber
was then washed by perfusion using PBS. The intermediate step of block-
ing with BSA ensures platelet activation is caused only the VWF bound
to the surface and any potentially exposed glass does not contribute to the
observed experimental results.
In parallel to platform preparation, whole human blood was drawn from
the antecubital vein of healthy donors who were not known to have taken
any medication within the previous 10 days, using a 19 gauge needle. The
first 5 mL of blood collected was routinely discarded to prevent any possible
activation of platelets, and blood was drawn into a clean polypropylene
syringe containing trisodium citrate as anticoagulant (final concentration of
0.32%, 1:9 ratio of citrate to blood). In the case of ReoPro-treated whole
blood, ReoPro (20 µg/mL in whole blood; Eli Lilly & Co., Indianapolis,
USA) was added to the whole blood sample 20 min prior to experimental
analysis. For fluorescence imaging of platelets, both whole blood samples
were labelled with 3,3’-dihexyloxacarbocyanine iodide (DiOC6(3)) (1 µM;
Invitrogen, USA), a fluorescent dye commonly used for platelet function
studies. The labelling was carried out by by addition and gentle mixing by
inversion followed by incubation for 10 min prior to experimental analysis
at 37oC.
Once the parallel plate device and whole blood have been prepared as
described, the device is placed over the microscope objective and the inlet
port is plumbed to a reservoir of whole blood, using 1/16’ inner diameter
SilasticTM tubing via 1/16’ threaded polypropylene connectors attached to
the devices inlet and outlet ports. The outlet port of the device is plumbed
to the pump via a syringe. Both the reservoir of whole blood and the chip
remain inside the temperature controlled chamber at all times during the
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experimental run.
Whole blood samples were assayed at a wall shear force (stress) of 6
N/m2, which, assuming a constant blood viscosity of 0.004 Pa.s (4 cP),
occurs at a volumetric flow rate through the device of 75 µL/min. This
corresponds to an arterial wall shear rate of 1,500s−1. In all cases, whole
blood samples were assayed within two hours of the initial blood draw, as
described. For each experiment, 3000 images (256 pixels x 256 pixels) were
recorded at a capture rate of 24 frames/s, corresponding to an overall run
time of 125 seconds; in that time, a total blood volume of 156 µL was
consumed. In comparison to the existing commercial system, wherein 5
mL would have been consumed under the same shear force conditions, this
represents a reduction of just under 97% in sample volume consumption.
In total, ten experiments were carried out, requiring ten parallel plate de-
vices to be fabricated as assembled. FIve of the ten experiments carried out
used whole blood treated with ReoPro, and five remained minimally treated
as described (DiOC6(3) and trisodium citrate as anticoagulant). The cap-
tured images from each experimental flow run, performed as described, were
then passed to a PC for investigations into the effect of ReoPro on whole
blood.
4.3 Analysis
4.3.1 Image Analysis
The image analysis strategy consisted of a number of sequential steps pri-
marily involving translating the captured image files into meaningful platelet
function data followed by the application of suitable data analysis tech-
niques depending on the metric under consideration. The first of these
sequential steps involved the development of a software algorithm to auto-
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matically determine platelets or platelet aggregates in a given image. Since
the detection method for platelets was based on fluorescence, the software
strategy utilised in platelet detection in a given image (frame) involved iden-
tifying areas of high fluorescent intensity relative to background from the
given frame. In order to automate this process and increase throughput, a
software package known as LabVIEW (National Instruments TX USA) was
utilised. LabVIEW is a graphical programming suite capable of employing
standard programming and data analysis techniques while also incorporat-
ing an extensive range of image processing capabilities making it a suitable
programming environment for the application in question.The systematic
approach implemented in LabVIEW can be seen summarised in Figure 4.2.
In practice, the user supplies the file name of an image, or an initial
image from a sequence of images to be analysed. In the case of a sequence
of images, each image file name is saved in numerically ascending order cor-
responding to the time point of capture. The custom software subsequently
analyses each image in ascending order from this user-defined image se-
quence, up until a user-defined number of images is reached or until the end
of the given sequence. Using this raw image (e.g Figure 4.2(a)) the software
automatically selects areas of high intensity representing platelet adhesion
events.
In order to determine what is to be considered an area of high intensity
and what is to be considered background data, an automated threshold
algorithm is implemented in LabVIEW. Any pixel value falling below this
calculated threshold value is deemed by the software to be background data
and given the numeric value 0 while any pixel value above the threshold is
given the numeric value 1 signifying particle detection at that pixel. This
automated thresholding algorithm comes predefined within the LabVIEW
suite of image processing capabilities. The calculated threshold limit (k) is
determined to be that pixel value k where the expression 4.1 is minimised.
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This threshold algorithm is implemented for each individual image ensuring
an optimum threshold value (k) is calculated for each image, thus accounting
for effects such as changing background due to increased areas of platelet
aggregation.
k =
i=k∑
i=0
h(i)|(i− µ1)|+
i=N−1∑
i=k+1
h(i)|(i− µ2)| (4.1)
where
 µ1 is the mean of all pixel values between 0 and k
 µ2 is the mean of all pixel values between k + 1 and N − 1
 i is the gray level value
 h(i) represents the number of pixels in the image at at each grey level
value
 N is the total number of gray levels in the image (256 in the case of
8-bit images)
Once the threshold algorithm has been applied to the image, the re-
sulting output is in the form of a binarised image, Figure 4.2(b), thereby
allowing the software to unambiguously detect the presence or otherwise of
a particle on a pixel by pixel basis. On obtaining the binarised image the
next step in the data analysis involves converting this binarised image to
a particle image or, in other words, converting the pixel by pixel data to
particle data. Housed within LabVIEW is a particle analysis suite of tools
that can store groups of contiguous non-zero particle clusters and record in-
formation related to particular attributes such as shape, size and location.
In this case, particle clusters of less than 35 pixels were determined empir-
ically to be contributing to extraneous noise and as such were disregarded
by the software.
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Figure 4.2: Result of image analysis algorithm
Each platelet or group of platelets is highlighted using a false colour and
also numbered against a constant colour background (See Figure 4.2(c)).
While there are some discrepancies between the raw and processed image,
the processed image does, in the main, correlate extremely well with the raw
image in terms of detecting locations and sizes of high fluorescent intensity
particles i.e. adhered platelets. For each of these detected particles, for ex-
ample particle number 24 in Figure 4.2(d), both the area of the particle itself
and its percentage contribution to the overall image area was calculated and
recorded based on individual pixel contribution (Figure 4.2(e)). The values
for particle number, overall cluster size and contribution to overall image
area was output to a spread sheet file for further analysis, Figure 4.2(f).
This entire sequence of steps was repeated for each image for a selected flow
run and data recored for subsequent analysis.
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4.3.2 Data Analysis
Since ReoPro inhibits the αIIbβ3 receptor on the platelet surface, it was
expected that this should affect both the amount of surface coverage via
its interaction with Von Willebrand Factor and also the amount of platelet-
platelet aggregation via fibrinogen-mediated platelet-platelet binding to ac-
tive αIIbβ3 on the platelet surface. To this end a dual approach was taken
to analysing the data as obtained from LabVIEW.
The first of these approaches involves summing the individual percentage
contribution to the overall image area of each detected particle in any given
image to gain an overall particle percentage coverage for that image. This
is then repeated for each image in a flow run and a plot of detected changes
in surface coverage can be generated for a single flow run.
The second approach takes the area of each detected particle (measured
in pixels) and outputs those values so that particle areas can be compared
with a view to determining aggregate sizes.
While there are a number of repetitive steps involved in the analysis,
the software has been designed such that the end user need simply specify
the initial image for a given flow run. The processes described have been
automated and run independently of user input once the first image from a
given sequence has been selected. This makes the software extremely user
friendly and requires limited technical ability to operate. For analysis of a
given flow run of 3000 images, the runtime of the analysis software, on a
2Ghz Core 2 processor, with 2 Gb RAM is under 60 seconds.
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4.4 Results
4.4.1 Surface Coverage
As anticipated, the resulting plots of detected changes in surface coverage
over time show clear differences between the untreated and ReoPro treated
whole blood samples. Figure 4.3 shows the plotted surface coverage for
each of the five untreated blood samples. The images on the right show
representative images of an untreated flow run at the beginning, middle
and final stage of an experiment. As can be seen from the images and as
indicated from the graph, the surface coverage of platelets increases over
time due to platelet-platelet and platelet-surface interactions.
Figure 4.3: Plot showing detected surface coverage of non ReoPro-treated
whole blood under physiological shear conditions in response to VWF
In contrast, the ReoPro-treated whole blood samples as shown in Fig-
ure 4.4 show an initial increase in detected surface coverage followed by a
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visible decrease in surface coverage detected. This initial increase in surface
coverage is mediated primarily by the interaction between the A1 domain
VWF on the glass surface of the device and Gp Ib/IX/V on the platelet sur-
face and can be seen to correlate well with the non ReoPro-treated data as
expected. The apparent reduction in surface coverage can be attributed to
ReoPro inhibiting receptor αIIbβ3 on the platelet surface and affecting the
platelets ability to adhere in a stable manner to the C1 domain of VWF. On
closer inspection of the images however, for example, the highlighted areas
on the ’MIDDLE’ and ’END’ images in Figure 4.4, it can be seen a photo-
bleaching effect contributes, at least partially, to this apparent reduction in
surface coverage.
Figure 4.4: Plot showing detected surface coverage of ReoPro-treated whole
blood under physiological shear conditions in response to VWF
Photobleaching is a photochemical destruction of a fluorescent molecule
caused by incident light. This can cause problems when studying time
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lapsed response of a fluorescent molecule, as the fluorescence decreases as a
function of the incident light. In practical terms this results in a ’dimming’
of the platelets adhered to the surface of the parallel plate flow device mak-
ing, fluorescently labelled, adhered platelets progressively difficult to detect
over time.
Figure 4.5: Plot of average detected surface coverage. Inset histogram of
average detected coverage taken at frame 2750
This detected difference between ReoPro-treated and non ReoPro-treated
whole blood can be further visualised if both sets of experimental flow runs
are averaged as shown in Figure 4.5. Figure 4.5 shows the average detected
surface coverage of ReoPro treated and untreated whole blood over the
experimental period of 125 seconds. The inset graph shows a histogram
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of average detected surface coverage from frame 2750 taken from the raw
data. The histogram data shows an approximately 40% reduction in de-
tected surface coverage on the ReoPro treated sample compared to the
untreated sample.
While a photo-bleaching effect can be seen to impact, at least partially,
on surface coverage analysis for ReoPro-treated whole blood, the software
does demonstrate the ability to detect differences in both ReoPro-treated
and untreated whole blood. However this experimental procedural effect
should not detract from the overall validation of the functionality of the
new device as a potential alternative parallel plate flow device for platelet
function studies.
4.4.2 Platelet Aggregation
In the case of platelet aggregation analysis, a selection of 10 images (frame
numbers 2745 - 2755) were taken as a representative snapshot of surface
coverage at a given time. A snapshot of 10 images would give information
for almost 0.5 seconds of data while also allowing noise to be averaged out
of the system. The area of every detected particle in each of the 10 images
was then recorded and a mean particle size and standard error recorded.
The average particle sizes for each flow run can be seen in Figure 4.6
As expected the ReoPro data has a significantly lower mean particle
size and smaller standard error than the untreated sample. Since ReoPro
inhibits fibrinogen-mediated platelet-platelet binding via receptor αIIbβ3,
this in turn inhibits the formation of platelet aggregates on the surface. In
contrast, the mean detected particle size for the untreated sample is signif-
icantly greater than in the case of the ReoPro-treated sample, indicating
larger platelet aggregates. Further, the standard error of these particles is
also significantly larger in the case of the untreated samples, indicating a
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Figure 4.6: Average platelet aggregate distributions on treated and un-
treated samples
larger spread of platelet aggregate sizes i.e. from single platelets to platelet
aggregates.
4.5 Conclusions
The newly designed parallel plate device was shown to function with sig-
nificant advantages over existing commercial systems. These advantages
are:
 The device can be permanently assembled, thereby eliminating the
requirement for extraneous hardware for ensuring a consistent seal
during a flow run. This sealing also facilitates a more reproducible
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and controlled environment for protein deposition as well as reducing
the amount of protein required of a single platform assembly.
 The reduction in flow path over the commercial device represents a
significant reduction in the flow rate required to generate a given shear
force (a reduction of approx 97% in the case of a physiologically rel-
evant shear stress of 6N/m2). This has significant implications when
running multiple tests on a single sample.
The functionality of the device and manufacturing strategy was vali-
dated using fluorescently labelled platelets in a whole human blood sample.
Five minimally-treated samples were passed through the device and a series
of fluorescent images of platelet interactions were recorded. Further, an
additional five samples were treated with a commercially available integrin
blocker used primarily for reducing platelet-platelet aggregations. These
samples were also passed through the newly designed parallel plate devices
under the same conditions as the minimally treated samples.
The effect of the integrin blocking agent, ReoPro, was investigated in
two ways. A software algorithm was developed to investigate both surface
coverage representing the αIIbβ3 VWF surface interaction while a particle
size distribution algorithm was developed to investigate fibrinogen-mediated
platelet-platelet binding via the αIIbβ3 receptor. In the case of the surface
coverage significant differences were seen in the profile of changes in surface
coverage over time. While some of these changes may be attributable, in
part, to a photobleaching effect, this experimental effect does not detract
from the fact that differences in ReoPro and non ReoPro-treated whole
blood samples under shear are observed in the newly designed parallel plate
flow device. In the case of particle size distribution, the untreated whole
blood shows both a larger average particle size and larger standard deviation
of particle sizes than the ReoPro-treated whole blood. This indicates a
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larger level of localised platelet-platelet aggregations as would be expected
under normal conditions in response to VWF.
In short the new device performs with diagnostic potential, requiring a
significantly reduced volume flow rate for a given flow run while also being
a more user-friendly device. Further, automated software was developed to
characterise these differences in a time-efficient, unbiased manner.
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Chapter 5
System Modifications
5.1 Introduction
In the previous two chapters the validation of a manufacturing technique for
the development of a parallel plate type platelet function device has been
reported. Further, in these chapters the development of a design based on
commercially available devices, its implementation and testing using custom
design software for validation of treated and untreated blood is described.
This chapter reports further system enhancements which builds on these
developments while also deviating significantly from the traditional parallel
plate type device and associated detection systems. Some of the problems
inherent in the parallel plate type device for shear-mediated platelet sur-
face studies are discussed while the advantages of a lower cost, dedicated
detection system which has the propensity to make these platelet function
tests more accessible to clinical laboratories are highlighted. The ultimate
goal is to make these entire systems readily accessible to a general practi-
tioners for a rapid low cost platelet function test. The first section of the
chapter details the deviations from the traditional parallel plate type device
and proposes a unique solution by combining two microsystem techniques
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without compromising shear-mediated response. In the remaining section
of the chapter the development of a dedicated bench-top readout system
incorporating the optical microscopy, fluid delivery, thermal stability and
software integration is discussed. This leads to a functional device compara-
ble to existing large scale, laboratory based, financially prohibitive readout
devices.
5.2 Chip Design
Among the main advantages of the parallel plate-type flow chamber is the
particular nature of the governing equations describing the device, ensur-
ing an almost constant wall shear force along the imaging wall. It is this
advantage of the device, however, that up until now has had negative im-
pact on the amount of sample required. Typical devices are on the order
of millimetres across while typical detection areas are on the order of mi-
crons. This results in a significant fraction of the sample passing through
the detection system undetected. Further, while the device as described in
Chapters Three and Four did provide a significant improvement over exist-
ing commercial devices in terms of required volume flow rate, the common
requirement for syringes and tubing for storing and delivering sample in,
resulted in the requirement for significant portion of sample dead volume
for any given flow run. Considering these disadvantages, a new type of flow
chamber was developed in an effort to:
1. Further reduce required sample volume for an entire experiment.
2. Efficiently utilise any sample passing through the device to ensure
maximum amount of sample passes over the detection area.
To this end, a platform was developed to combine the advantages of
the parallel plate flow chamber exploiting the microscale nature of the flow
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regime by utilising a variation of the hydrodynamic flow focussing effect
shown in Chapter 1.
Figure 5.1: Dual inlet platelet flow device
Figure 5.1 shows an illustration of the proposed device. Figure 5.1 (a)
shows an exploded view of the device while Figure 5.1 (b) and (c) shows
the chip in assembled form as schematic and actual device, respectively. In
contrast to the previous (single inlet) device described in Chapters Three
and Four, this (dual inlet) device uses multiple layers of adhesive material
to form a three dimensional flow chamber. The ability of the PSA to be pat-
terned and stacked sequentially makes this a very attractive option for chip
manufacture and opens up another avenue for conceptual design and manu-
facture of microfluidic devices. The resulting effect of this three dimensional
configuration results in the sample flow stream being focussed towards the
centre of the device while also being shaped in such a way as to ensure con-
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tact with the protein-coated activating wall where shear-mediated platelet
surface interactions are being investigated. This hydrodynamic ’shaping’ ef-
fect is mediated by the introduction of a buffer solution which runs through
the device in tandem with the sample as shown in Figure 5.2. Since flow in
micro devices is primarily laminar in nature, the introduction of this sec-
ondary/buffer flow will have minimal impact on the physiological compo-
nents of the blood stream. Any mixing will be primarily a diffusive process
and at appropriate flow velocities can be deem insignificant to the operation
of the device.
Figure 5.2: Schematic of the hydrodynamic shaping effect in parallel plate
flow configuration.
This dual inlet chip is manufactured in a similar manner to the single
inlet chip as described earlier.
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For the top plates, 6-mm-thick PMMA stock (Ensinger Plastics, UK) is
machined to standard microscope slide dimensions, 75 mm long x 25 mm
wide, using conventional milling. This piece is then drilled and tapped to
accept inlet and outlet connection ports.
The middle layer materials, which define the flow path, are manufac-
tured from the same commercially available double-sided pressure-sensitive
adhesive (PSA) laminate. ArCARE 8890®(Adhesives Research, Limerick
Ireland) is a 12.5-µm polyester film coated on both sides with a medical-
grade acrylic adhesive, resulting in an overall thickness of 50 µm. The flow
path layers were cut using a Coherent GEM-100liquid-cooled CO2 laser
embedded in a Micromaster Turnkey dual-head laser system from Optec SA,
Belgium. As with the top plate, the outer dimensions of the PSA laminate
layer correspond to microscope slide dimensions.
The base layer of the platform was chosen to be a commercially available
glass microscope cover slip. This base material was chosen since high quality
glass cover slips are a widely available commodity with tightly controlled
dimensional, optical, and surface-finish tolerances, in addition to having
predictable and reliable surface chemistry.
Figure 5.3: Dimensions of pressure sensitive layers. Buffer layer shown left
and Sample layer shown right.
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In terms of dimensions of both flow defining layers, the main flow channel
of the ’Buffer Gasket Layer’ as indicated in Figure 5.3, is patterned to be 4
mm wide in order to maintain the same aspect ratio as the previous single
inlet device (1:400). Each of the bifurcated channels is 2 mm wide in an
effort to minimise the pressure drop when recombining with the overall
channel width of 4 mm. The main channel length was designed to be 35
mm in order to provide flexibility in terms of imaging and to ensure imaging
could be carried out down stream of any entrance length effects in the
main channel of the device. Further to the flow defining channels there
is also a 5mm diameter hole in the gasket allowing sample access to the
‘Sample Gasket Layer’. The ’Sample Gasket Layer’ as indicated in Figure
5.3 contains the same main channel dimensions of 4mm wide x 35 mm long
and height defined by the gasket thickness of 50 µm. The entrance area
consists of a 750 µm wide x 10 mm long channel for sample delivery to
the device. Further, the layer contains a similar bifurcation to the ’Buffer
Gasket Layer’ allowing for buffer fluid entrance effects to be minimised as
much as possible before introduction to the sample entrance area.
Assembly of the device is also carried out in a similar manner to the
single inlet device. The glass cover slip is placed in a custom designed
alignment jig while sequential layers of patterned PSA are added (as in-
dicated in Figure 5.1) followed by the top plate of the device. The entire
fixture is then pressed together through two rollers to form a sealed device.
As described previously the platform undergoes a thorough cleaning pro-
tocol involving a wash step with absolute ethanol which is then allowed to
evaporate prior to chamber assembly and rinsing by perfusion with aqueous
buffer (PBS) post assembly.
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5.2.1 Chip Operation
In terms of standard device operation, the device operates under a summa-
tion of flow rates principle. The application of a negative pressure, typically
via a pump, at the outlet generates a volume flow rate (Qo) through the
device. In order to satisfy conservation of momentum this flow rate Qo
must, equal the sum of both the flow rate through the buffer inlet (Qb)
and flow rate through the sample inlet (Qs). If, however, the volume flow
rate through the buffer inlet Qb was also independently controlled, via an
additional pump, this in turn would facilitate indirect control of the sample
flow rate Qs through the device for a given fixed outlet flow rate. In other
words
Qs = Qo −Qb
In principle, for a fixed outlet flow rate Qo there are three possible out-
comes
 Qb = Qo ⇒ Qs = 0. (Resulting in no net sample flow.)
 Qb > Qo ⇒ Qs is -ve. (Resulting in sample flow out from the device.)
 Qb < Qo ⇒ Qs is +ve. (Resulting in sample flow through the device.)
For the remainder of this Chapter consideration will only be taken to
the case where Qb < Qo i.e sample is flowing though the device.
Consider the case where the outlet flow rate of the device Qo is fixed at
0.6 mL/min (corresponding to a physiological shear rate of 1500 s−1). For
a fixed buffer flow Qb of 0.4 mL/min and in order to maintain the principle
of conservation of momentum this results in the flow rate of sample (Qs)
through the device being 0.2 mL/min. Figure 5.4 illustrates the effect of
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varying the buffer flow rate Qb over a range of flow rates for a fixed outlet
flow rate of Qo of 0.6 mL/min.
As can be seen from Figure 5.4 as the buffer flow rate is increased the
sample volume (red dye) through the device becomes narrower. However
since the overall flow rate through the main channel is constant the shear
force imparted on the wall remains constant. It should be noted that there
are relative fluid viscosity issues to be taken into consideration and these
will be dealt with in the following sections. In this case, however, both dye
and water were considered to have the same viscosity (0.001 Pa.s). In an
effort to gain a more quantitative impression of events occurring as buffer
flow rate is varied with respect to a fixed outlet flow rate, the images in
Figure 5.4 were further analysed.
Figure 5.5 show the effect of varying the buffer flow rate between 0.4 and
0.59 mL/min for a fixed outlet flow rate of 0.6 ml/min. The graphs were
obtained by taking a 10 pixel wide sample band through the centre of each
of the images shown in Figure 5.4. A representative sample band in shown
in Figure 5.5 (a). The pixel values in the ’Y’ direction as indicated in Figure
5.5 (b) were averaged and plotted against the corresponding pixel position
’X’ as indicated in Figure 5.5 (b). Figure 5.5 (c) shows the resulting plots of
sample widths over the range of buffer flow rates as described. As expected,
as the volume flow rate of buffer increases relative to a fixed outlet volume
flow rate, the amount of sample passing through the chip is seen to visibly
decrease. Since the sample flow rate through the device is now independent
of overall flow rate through the device this means significantly less sample
is required for a given experimental flow run. This reduction in overall re-
quired sample, also facilitates alternative sample delivery techniques to the
device. Since sample flow rate through the device is on the order of µL/min
and any dead volume requirements have been circumvented by the intro-
duction of the buffer solution, µL sample volumes can be delivered directly
99
CHAPTER 5. SYSTEM MODIFICATIONS N.J.Kent
0.4mL/min 0.44mL/min
0.48mL/min 0.52mL/min
0.56mL/min 0.58mL/min
Figure 5.4: Flow variation due to hydrodynamic shaping
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Figure 5.5: Profiles of observed variations in sample width caused by vari-
ations in buffer flow rate.
into the sample inlet port of the device, without compromising device func-
tion. This method of delivering sample also has the potential to facilitate
a ’finger stick’ type approach for sample delivery, thereby eliminating the
requirement for citrated blood and also making the entire procedure more
patient friendly compared to a relatively intrusive blood draw via syringe.
In order to gain a deeper understanding of this shaping effect and to
allow more flexibility in its exploitation, a Computational Fluid Dynamic
model of the device was developed. In a similar manner, to the single inlet
device previously described, the symmetry of the device could be utilised
in the preprocessing stage of model development in order to maximise run
time while minimising the computational power required for a convergent
solution.
Figure 5.6 shows the grid generation stage of the model development
which highlights the symmetrical nature of the model. In contrast to the
single inlet device, symmetry is only available in a single dimension for the
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Figure 5.6: Dual-inlet device schematic and CFD model highlighting device
symmetry.
dual inlet device, thereby resulting in a model containing 20875 nodes and
15544 cells. In order to improve accuracy of the model in the area sur-
rounding the shaped stream, a technique known as power factor reduction
of the mesh size, was implemented. Power factor reduction essentially, in-
creases cell density in the areas of interest of the model (in this case, along
the centre stream) at the expense of a reduction of cell density in areas of
less interest on the model. The net effect of power factor reduction is an
improvement in resolution of modelled data output in the areas of interest,
at no extra computational cost. This is offset by a reduction in data quality
in areas of less interest in the model. For simulation purposes both the
platform outlet and buffer inlet of the device were modelled as inlets and
the sample inlet of the device was modelled as an outlet.∗ A symmetrical
wall boundary condition was placed on the wall as indicated in Figure 5.6.
For the simulation phase, buffer was modelled as a continuum fluid with
a density (ρbu) of 997kg/m
3 and a dynamic viscosity (µ) of 0.004Pa.s while
∗From a modeling perspective any active inlet or outlet i.e. any port connected to a
pump is typically modelled as an inlet. Similarily any non active port (in this case the
sample inlet port) is typically modelled as an outlet.
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blood was also modelled as a continuum with a density (ρbl) of 997kg/m
3
and initially with a matched viscosity of 0.004Pa.s
The symmetrical boundary conditions, as described, were imposed on
the geometry and the mass flow rate through the model outlet was deter-
mined to be 2.5 x 10−6kg/s. This value was found using equations developed
in Chapter 2 and taking into account the symmetrical boundary conditions
and based on a wall shear stress of 6N/m2, representative of a typical vas-
cular shear stress. The buffer flow rate was inputted over a range of 7 values
from 2.45 x 10−6kg/s. to 1.66 x 10−6kg/s. in increments corresponding to
the flow rate increments as described in Figure 5.5. The default solver for
CFD ACE+ utilises the finite volume method as described in Chapter 2 and
running the model under these conditions resulted in a model convergence
after an average of 57 iterations per analysis with a total run time for all 7
variations in buffer inlet flow rate of 482 seconds.
Once the results for each buffer flow rate had been calculated this was
compared to the experimentally derived image analysis data from the actual
device in an effort to validate and further utilise the model to gain more
information specific to its application as a platelet function device. In order
to perform the validation, the interface between buffer and sample as cal-
culated by the model was compared to the experimentally derived interface
between the buffer and sample as shown in Figure 5.5.
Figure 5.7 shows the correlation between the buffer sample interface as
obtained experimentally (solid lines) and those obtained using the compu-
tational model (dashed lines). While there are variations between modelled
and experimental data, the model can be seen to correlate extremely well
with image data in the area of flow rates of interest as shown in Figure 5.7.
In areas of apparent disparity, (e.g area of Figure 5.7 labelled ’Diffusion’)
the magnitude of error can be attributed to the fact, the model neglected
any diffusion effects between sample and buffer solution while this diffusion
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Figure 5.7: Plot of comparisons between modelled and experimentally de-
rived buffer-sample interfaces for a fixed outlet flow rate and over a range
of buffer flow rates.
gradient is clearly visible in the image data. Furthermore, considering the
cell-to-cell distance of the model increased laterally away from the centre of
the model due to power factor reduction of the mesh, disparities between
model and image data in these areas of reduced interest were expected.
In general, however, the computational model compared favourably to the
experimental results in terms of rate of reduction of sample stream with in-
creasing buffer flow rate and, as such, was deemed a valid model for further
investigations into the effect of hydrodynamic shaping.
Of significant importance to the reproducible functionality of the device
is the determination of entrance length effects of the device and also the
effect of a mismatch in the viscosities of both buffer and sample.
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Entrance Effects
Since, for a constant wall shear stress in the main channel, the outlet flow
rate must remain fixed, varying the buffer inlet flow rate can have dramatic
effects on the shear stress generated in the sample channel. If the volume
flow rate through the buffer channel is reduced, in order to conserve the
overall mass flow rate through the device, the sample channel flow rate
must increase by the same volume flow rate. Due to the relative channel
cross sectional areas, however (buffer channel cross-sectional area≈ 11 times
sample channel cross sectional area), this increase in sample channel volume
flow rate dramatically increases the sample velocity through the sample
channel inlet.
Figure 5.8: Computational model showing shear stress distribution through
the dual-inlet chip for an outlet flow rate of 0.6 mL/min and a buffer flow
rate of 0.59 mL/min. The graph on the right shows a plot of max shear
stress in the sample channel over a range of buffer flow rates for a fixed
outlet flow rate fixed of 0.6mL/min.
This increased sample flow velocity directly impacts viscous shear force
generated at the wall of the sample inlet channel. To this end, the maximum
wall shear stress through the sample channel for each buffer flow rate was
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plotted against buffer flow rate and the resulting graph is shown in Figure
5.8. Figure 5.8 shows the shear stress distribution along the centre plane of
the dual inlet device (in this case for a buffer flow rate of 0.59 mL/min) The
graph to the right shows a plot of maximum (wall) shear stress (as indicated
in Figure 5.8) along the sample channel for each given buffer volume flow
rate. As can be seen from the graph, reducing the buffer flow rate for a fixed
outlet flow rate (in this case 0.6 mL/min) significantly increases the wall
shear stress generated along the sample channel. Under normal operation,
the shear stress in the main channel is fixed at 6N/m2 In order to ensure
that this is the maximum shear stress applied to the sample, based on the
obtained linear relationship, the buffer flow rate should be greater than
0.5688 mL/min. Any flow rate less than 0.5688 mL/min would result in
a shear stress greater than 6N/m2 in the sample channel, thereby causing
potential platelet activation prior to platelets entering the test area of the
device.
Figure 5.9: Visualisation of velocity profile development through the chip.
The graph on the right illustrates the velocity profiles in the direction of the
flow along the center of the chip as indicated. Each profile, 1-10, as shown
on the graph corresponds to location 1-10 as shown on the model.
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The model was then re-simulated using this buffer volume flow rate of
0.5688 ml/min and investigations into flow development were carried out.
As in the case of the single inlet platform, as the flow stream enters the
device there is an entrance length over which the flow profile goes from a
transitional state to a characteristic fully developed parabolic flow profile.
Figure 5.9 charts the progress of the velocity profile as it moves from the
sample entrance area to further down the main channel of the device. The
graph on the right of Figure 5.9 shows the velocity profile taken at each
position as indicated on the CFD model. As the flow progresses down
stream the profile becomes more developed until it can be assumed to be
fully developed at position 5 as indicated in Figure 5.9 corresponding to
just over 3 mm downstream of the sample entrance position.
Figure 5.10: Computational model of buffer progression through the device
for a maximum practical buffer flow rate of 0.5688 mL/min
Further, the development of the sample stream through the device at
the minimum practical flow rate of 0.5688 mL/min was investigated. Figure
5.10 shows the progression of the sample stream as it enters the main channel
and traverses through the main channel of the device.
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Viscosity Mismatch
All the model data above were based on the assumption of equivalent buffer
and sample viscosities (µ = 0.004Pa.s) resulting in a wall shear stress of
6 N/m2. In practice however there may be slight discrepancies between
the buffer and sample viscosities over a range of sample heights within the
main channel. Chapter 2 dealt with the development of equations describing
two fluid flow of varying viscosities at various heights between two parallel
plates. Utilising these equations the effect of a mismatch of viscosities
between buffer and sample, as a function of channel height were tabulated.
Buffer Sample Wall Shear Force (N/m2) at
Viscosity Viscosity Various Sample Heights
(Pa.s) (Pa.s) 10µm 25µm 50µm 75µm 100µm
0.004 0.003 6.3 6.5 6 5.2 4.4
0.004 0.0035 6.1 6.3 6 5.6 5.2
0.004 0.004 6 6 6 6 6
0.004 0.0045 5.9 5.8 6 6.3 6.7
0.004 0.005 5.9 5.7 6 6.6 7.5
Table 5.1: Table showing the effect on wall shear force of varying sample
viscosity and sample height in channel.
Table 5.1 shows the effect on sample height on wall shear stress over a
range of viscosity values from 0.003 to 0.005 Pa.s for a fixed buffer viscosity
of 0.004 Pa.s. In the case where both, sample viscosity and buffer viscosity,
are 0.004 Pa.s, no net effect on wall shear stress is observed, since relative
viscosities remain constant.
However, in cases of mismatches between sample and buffer viscosities,
the effects relative height, on wall shear stress are observed. For example,
in the case of a sample viscosity of 0.003 Pa.s, at an in channel height of 10
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µm, the calculated wall shear stress is 6.3 N/m2 as opposed to the desired
shear stress of 6 N/m2. As the relative height increases to 100µm, this wall
shear stress is seen to decrease to a value of 4.4 N/m2. It is worth noting
that these figures were calculated on the basis of infinitely wide parallel
plates as described in Chapter 2.
In practice, the fact that the buffer surrounds the sample stream from
both sides, rather than creating the idealised modelled scenario, would serve
to reduce the mismatch between desired and actual wall shear stress. Since
the buffer, of known viscosity, surrounds the sample stream from both sides
and on top, the buffer stresm would have a greater influence on the wall
shear stress through the device than calculated in the idealised parallel plate
flow case.
Also of relevance is the fact, the most significant deviations between
desired and calculated wall shear stress, occur at a height of 100µm, or in
effect, when there is no buffer flow through the system. This has impli-
cations when using the standard single inlet-single outlet flow chamber as
any deviation between mean and actual blood viscosity may result in ex-
perimental error †. While this effect is not eliminated using the dual-inlet
device the introduction of a known viscosity buffer serves to reduce this
experimental error.
5.3 Detection System
In parallel with the development of the new platelet function fluidic device
a dedicated readout system was also developed. Current systems are, ex-
pensive, bulky, require significant technical expertise to operate and do not
†While it is possible to measure each individual whole blood sample, this is imprac-
tical in terms of both time and cost for any given flow run. Many laboratories calculate
required volume flow rates based on a whole blood viscosity values taken from literature
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lend themselves well to the potential point of care setting, that the newly
designed platform has the capacity to operate within. To this end, a new,
bench-top, user-friendly readout system was designed and developed. This
detection system comprises three main sub assemblies, each having the ca-
pacity to operate independently or as part of the overall system. Each of
the sub-assemblies are detailed in the following section.
5.3.1 Readout System Sub-assemblies
Optical
The optical system for fluorescent platelet detection was configured in an
epi-fluorescent format as shown in Figure 5.11 with a blue laser diode (Pho-
totmetrics, excitation wavelength 473nm) used as an excitation source. This
beam was expanded, collimated and subsequently reflected from a dichroic
mirror through a 20x objective. The spot size generated through the ob-
jective can be tuned using the expansion optics. However for the purposes
of the platelet readout device, the spot size is approx. 500 µm thereby
generating an even illumination over the detector field of view. On excita-
tion with blue light, any resulting fluorescence passes through the objective
and the dichroic mirror, becomes reflected from a standard mirror, passes
through an optical band pass filter, and falls on the charged coupled de-
tector (CCD) device (Prosilica EC1350 series firewire device). This CCD
sensor lies 160mm from the base of the objective, corresponding to the
manufacturers tube length guidelines where by magnification of 20x is en-
sured. The excitation source, associated optical filters and mirrors are all
readily interchanged, thereby increasing the flexibility of the microscope for
investigations into use of different fluorescent stains. In the case of our
experiments, however, the excitation source and filter set were chosen to
match the previously used DiOC6(3) in terms of optimisation of fluorescent
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signal capture. See inset graph Figure 5.11 for spectral data.
Figure 5.11: Schematic showing design principle of epiflourescent micro-
scope with actual device inset
In terms of resolving platelet surface interactions, since the magnification
of the objective is 20x and the each pixel of the CCD detector is 4.65 µm,
this results in sub micron resolution of image capture.
4.65µm
20
= 0.2325µm
In the case of a 2 µm platelet, (assuming circular platelets) this results
in
Convert µm to pixels
(
1
0.2325
)
⇒ 1 µm platelet radius ≈ 4.3pixels
Area covered = pir2 ≈ 58pixels2
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Similarly, in the case of a 4 µm platelet the corresponding image size is
≈ 232 pixels2 and, this was deemed not to pose any problem in terms of
imaging.
Figure 5.12: Distribution of detected particle sizes
In order to test cameras capability a sample program was written to
analyse an image and calculate detected particle area. For the purposes of
camera testing particles touching the edge of the image and also platelet-
platelet aggregates (shown in blue in Figure 5.12) were omitted from the
analysis. As shown in Figure 5.12 the average particle area is 170 pixels2
falling within the theroetical camera range of 58 - 232 pixels2. These images
are captured via the CCD and transmitted via firewire connection to a
laptop computer for further analysis.
The translation stages for the microscope consist of three manually oper-
ated linear stages commercially available from Thor Labs US. These stages
were assembled and facilitated linear movement of the microscope stages in
X,Y and Z directions as indicated in Figure 5.13.
To enable focussing of excitation light onto the chip, a specially designed
platform holder was manufactured and assembled as part of the Z direction
stage. This holder was designed to promote efficient and reproducible inter-
change of the newly designed platelet function platforms. Further, both the
optical housing and the stage material were chosen to be machine-shop grade
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Figure 5.13: Schematic showing stages assembly with designed platform
holder
aluminium that was machined using conventional machining techniques and
subsequently anodised black to eliminate stray reflections. Aluminium, as
a material choice, is robust for its intended application and also exhibits
extremely good thermal conductivity (237 W.m1.K1) making it an ideal
choice of material for use in promoting thermal control and stability of the
platelet function platform itself.
Thermal
In terms of thermal control for the platform, the aluminium platform holder
was actively heated using two polyimide resistive heaters (HK5165R52.3L12
from Minco,UK). These heaters were sealed to the underside of the platform
holder as shown in Figure 5.14 . The heaters operate up to 3A and are capa-
ble of delivering 15 Watts of power at a 28V supply. Under these maximum
operating conditions, the upper surface of the chip holder theoretically in-
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creases in temperature by almost 8  per minute, thereby resulting in an
increase to 37 , of the holder, in less than three minutes. In practice how-
ever, using a 12 V supply, and taking into account the microscale surface
roughness of the chip holder, combined with the thermal conductivity of;
the glass, the pressure sensitive adhesive layers and polymer, this results in
the actual chamber taking significantly longer to reach the required 37 
equilibrium.
Figure 5.14: Image showing image of polymide heaters (left) and image
taken from IR camera under active heating (right). The active elements
can be seen to heat to 45 while the overall platform remains at 38.5 
In order to control heating of the platform holder, a temperature stabili-
sation technique was introduced. This technique allowed the temperature to
be stabilised at a user-defined set point via a software controlled feedback
loop. The temperature of the aluminium block was independently mea-
sured using miniature 10kΩ NTC thermistor coated with a black stycast
epoxy (10K4A1AM, from Betatherm, Ireland). These temperature data
were sent to a LabVIEW program on board a PC via an electronics control
card housed within the microscope stages as shown in Figure 5.17. The
measured temperature value was compared to a user-defined temperature
and the discrepancy between the desired and actual dictated the length of
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time the heaters remained in the ’on’ or ’active’ state. As the measured
temperature approached the user-defined set point the activation time of
the heaters was dramatically reduced. Although in many thermal stability
systems there is both active heating and cooling it was felt the introduction
of an active cooling mechanism, typically a fan, would introduce unneces-
sary complications to what was designed to be a relatively simple detection
system and, as such, ambient cooling was deemed acceptable. This was
further justified because under normal operation the chip holder would not
require rapid thermal cycling i.e. active temperature increase to a single set
point was the main requirement for reproducible device operation.
Although directly controlling the ’in channel’ temperature of each platelet
function platform independently would be desirable, this would involve in-
troducing a thermistor into the channel of each device. This, it was deemed,
would have a negative impact on chamber operation as measuring the tem-
perature directly at the point of interest would ultimately disturb the flow
profile at the point resulting in local disturbances in calculated shear force.
Further, the introduction of commercially available thermistor epoxy into
the channel could in itself promote changes in platelet function independent
of deposited protein coating. As a result, an indirect approach to temper-
ature control was taken. A small hole was drilled in the chip holder where
a thermistor was embedded, as shown in Figure 5.15. Measuring and con-
trolling the temperature of the chip holder facilitated indirect control of
the temperature of the chip itself. While the ability to directly control the
’in channel’ temperature is unambiguous, using the indirect approach to
control chip temperature introduces additional operational considerations.
Although the thermally conductive chip holder may be at a user defined
set point, it would also be necessary to investigate the effects of thermal lag
(delay in thermal response) and thermal loss from chip holder to the chip
itself. To this end, a chip was manufactured as described with the exception
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of a small (dia 1.6mm) hole drilled through the polymer top plate. This
hole was drilled in the centre of the main channel at a distance 25mm from
the sample entrance zone as shown in Figure 5.15. The entire chip was
filled with a thermally stable oil in order to minimise convective heating
effects in the channel. Additional 10k thermistors (Betatherm, Ireland)
were embedded in both the drilled hole as described and also the sample
reservoir which had also been filled with the control oil.
Figure 5.15: Measured temperature over time from various area of chip and
chip holder as indicated
Prior to experiments, the chip with embedded thermistors was allowed
to sit at room temperature for at least two hours to ensure temperature
stabilisation across the chip. In order to investigate the effect of thermal
lag and loss, the heating control was activated and the heater was allowed
to reach its defined steady state. On reaching steady state, the chip with
embedded thermistors, measuring both channel and reservoir temperature,
was introduced to the holder and the temperature monitored.
To investigate thermal loss, the required set-point was adjusted from
37oC to 42 oC in increments of 0.5oC and thermal lag was measured by
observing the time delay from chip introduction to the device until chip
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steady state temperature was reached. It was observed experimentally that
thermal loss for the system was 1.5oC while thermal lag was measured to
be approx 500 seconds. This resulted in a required set point of 38.5oC as
shown in Figure 5.15. Figure 5.15 shows the measured temperature response
from the actively heated chip holder and also the resulting temperature
increase in both the reservoir and channel. It can be seen that while the
thermal response of both sample and channel are relatively uniform there
is a significant lag time before the chips reach a steady state of 37 oC
which should be taken into account for in order to ensure experimental
reproducibility when dealing with biological samples.
Fluid Delivery
For actuating fluid movement through the device a commercially available
syringe pump was sourced from Cetoni (Cetoni.de) See Figure 5.16.
Figure 5.16: NEMESYS pumping system from Cetoni.de. Image shows
pump base station and five pumping modules
The NEMESYS pumping system is a high precision syringe pump capa-
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ble of delivering flow rates from 0.494 µL/s up to 2.494 mL/s. The pump
consists of a base station containing the hardware control, USB connection
for software control and a single syringe pump with universal syringe holder.
Among the more attractive features of the pump however is the ability to
extend functionality by the addition of individual independently controlled
pumping modules. Coupled with its relatively small footprint (310 mm x
207 mm x 80 mm) and the ability to develop custom software for pump
control, the NEMESYS was an ideal choice for independently controllable
delivery of two fluid streams over a range of flow rates. Further, however, it
was the technical specifications of the power supply, of the NEMESYS sys-
tem that made it the fluid delivery method of choice for the platelet function
detection system. The ability to exploit additional unused terminals on the
output terminal of the NEMESYS power supply allowed the pump power
supply be further utilised to power, the laser diode excitation source and
also the heater, thereby making the developed system extremely compact
and portable.
Integration
In terms of development of a single detection and readout system, the sub-
assemblies as described required integration on a mechanical, electronic and
software level. In terms of mechanical integration, both the microscope op-
tical block and stages were fixed relative to each other by a 21 mm thick
black nylon plate. Further, the outer dimensions of the black nylon sup-
port plate was machined to match the outer dimensions of the NEMESYS
pumping system and fixture holes were drilled to match the hole template of
the NEMESYS system. On an electronic level, as previously mentioned the
power supply used for the pump motors was a step down (240V AC to 24
V DC) transformer with a 5A capacity, thereby making it a capable power
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supply for all sub-assemblies. Coupled with the suitable specifications was
the fact there were a number of unused outputs from the transformer. These
outputs were utilised for each sub system. In the case of the laser system, a
24V to 6 V 1A regulator was used to output the required voltage and a 0.33
µF and 0.1 µF Capacitor placed in parallel across the regulator input and
output respectively in order to minimise the effect of noise on the system.
Similarly in the case of the heater power supply, the 24 volt supply from
the NEMESYS system was used and a 24 volt to 12 volt 2A regulator was
integrated into the NEMESYS pump. The addition of both regulators in-
troduced the requirement for a heat sink to be included as part of the overall
system. The heat sink (ABL Components) was rated at 1.2 oC/W. This
relatively high thermal resistance was required when dealing with the 24V
to 12V regulators which draw up to 1.5 Amps of current over approximately
250 milliseconds (thereby resulting in approximately 4.5 Watts of power to
be dissipated). Incorporated as part of the laser and heating systems, were
independent on/off switches allowing functionality of each of the subsys-
tems independently or as part of the overall system. Further included in
the electronics integration was the development of additional heating con-
trol circuitry to facilitate software controlled switching of the heating power
supply. The measured thermistor readings for the thermal control were fed
through a dedicated LabVIEW compatible electronics card enclosed in the
microscope stages as indicated in Figure 5.17.
Also enclosed within the housing was a relatively simple ’H’ bridge cir-
cuit linking the output from the LabVIEW card to the output from the
pump power supply. This circuit essentially acts as a switch for the high
voltage (12V) line. If the software deems the heater should be turned on
it sends a 5 volt signal to the ’H’ Bridge which activates the 12 V supply
across the heaters. When the software deems the heaters should be off, the
signal goes to 0V and the switch becomes inactive. Using this method for
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heater activation it was possible to use standard PC power supplies of 5V
and 300mA to control a higher voltage 12V 2A supply.
In terms of software integration, the entire system was fully integrated
into a single software program capable of heater control, pump activation,
camera configuration, image capture and software analysis. As part of the
prerequisite for many of the components sourced (in particular the CCD
camera and pumping system) the ability to be independently controlled via
software, typically LabVIEW, was of significant importance. The ability
to control each sub-assembly via software would improve ease of use of
the overall system while also facilitating the ability to more easily record
experimental parameters such as pump flow rates or camera settings to
ensure experimental consistency over a number of experiments.
Figure 5.17: Image of developed miniturised platelet function analyis system
The entire assembled system can be seen in Figure 5.17. In its current
embodiment, the end-user currently has control over the set point of the
heater control while a visual display graphs the temperature of the platform
holder. In terms of fluid delivery, the end user can input various syringe
parameters for two independently controlled pumps and actuate either or
both of these pumps in any given directions at any speed permissible by the
pumps hardware. In terms of image capture, the end user defines the saving
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location of the images and also the image format and number of images
required, while the brightness, gain and shutter speed of the camera are all
user-definable depending on the fluorescent intensity of the capture medium.
In terms of costings for the overall system, an approximate breakdown is
shown in Table 5.2.
Description Cost(Euro)
Pump System 3,500
CCD Camera 1,500
Laser Diode 1,400
Laptop 1000
Filter Set 450
Stages 450
Custom Machining 450
Labview Hardware 100
Microscope Objective 80
Total 8930
Table 5.2: Approximate costings for Platelet Function Readout System
The total cost of the detection system is approximately 8930 euro. In
order to gain some perspective on the overall cost of the detection system,
a camera for the large scale laboratory system was recently purchased for
a cost of 10,000 euro. The ability to deliver an entire readout system at a
comparable cost to a single component of existing systems represents sig-
nificant savings and makes the detection systems more amenable to clinical
and GP settings.
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5.4 Conclusions
An entirely unique approach has been taken to the traditional parallel plate
style of device for shear-mediated platelet function analysis. By combin-
ing the existing parallel plate technology with variations on hydrodynamic
focussing in a laminar system, the initial goals of a further reduction in
required whole blood sample while also maximising sample efficiency were
realised. The designed platform was manufactured in a manner suitable
to both prototyping and mass production techniques. The functionality
of the new device, in terms of fluid ’shaping’, was then validated using
coloured dyes. This experimental data were then validated against a three
dimensional computational fluid model of the device. This model facilitated
predictions related to, appropriate buffer flow rates for a defined sample
channel shear stress, changes in buffer-sample interface over various flow
rates and also entrance length effects for both buffer and sample. Finally,
the theory initially developed in Chapter 2, was expanded to show the effect
of a mismatch in viscosity of both buffer and sample streams.
In parallel with the extensive characterisation of the new platelet func-
tion device, a miniaturised detection system was designed and assembled.
The device integrates a number of sub assemblies critical to the repro-
ducible assaying of whole blood samples. In the case of optical detection, a
miniaturised epi-fluorescent microscope was designed and built using laser
diode excitation and appropriate filters for the detection of suitable dyes for
platelet function analysis and image capture via CCD. The microscope stage
incorporated active heating elements in order to maintain the platform at
a constant 37 . The fluid delivery system was sourced commercially and
was capable of independently delivering two fluid streams over a range of
volume flow rates suitable for generating appropriate shear stresses in the
newly designed platform. In terms of integration, each of these sub assem-
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blies was mechanically assembled to form a single portable bench top detec-
tion system. Further, these sub assemblies were could be independently or
simultaneously controlled via customised software. The software facilitated
thermal control, flow control and image capture control of the bench top
detection system all from a single user interface on a laptop computer.
In short, a novel platelet function platform was developed capable of
testing sub 500 µL samples of whole blood under shear-mediated flow con-
ditions. In parallel, a low-cost, bench-top, detection system was developed
specifically with the new platelet function platform in mind. The next stage
of development involved validation of the entire system with whole blood
samples.
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Results and Analysis II
6.1 Introduction
On completion of the design and fabrication of the dual inlet platelet func-
tion diagnostic chip and, in conjunction with the construction of the desktop
readout device, the final stage of development was to investigate the poten-
tial of the entire systems to return diagnostically relevant information.
To this end the series of experiments as described in Chapter 4 was
repeated. As before, an total ten tests was performed. Of these ten, five
samples were treated with Abciximab and five remained untreated. The
rationale for utilising Abciximab as the drug of choice has been detailed in
Chapter 4.
As a reminder, Abciximab, sold under the trade name ReoPro, pro-
vided an attractive option as a test case for the entire platelet diagnostic
system as it facilitated the ability to carry out multi-parameter testing.
Since ReoPro inhibits both stable adhesion of platelets on VWF and also
fibrinogen-mediated platelet-platelet binding, this allowed for a dual anal-
ysis approach focussing on each interaction independently. As in the case
of the single inlet single outlet chip, the output metrics from the dual inlet
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platelet function chip in conjunction with the miniaturised readout system
were the ability to detect
 changes in surface coverage over time, thereby providing characterisa-
tion of the inhibition of αIIbβ3 on stable platelet adhesion to VWF.
 platelet cluster analysis after a predefined length of time, thereby
characterising the inhibition of fibrinogen mediated platelet-platelet
aggregation.
6.2 Experimental Procedure
Experimental procedure was kept consistent with the procedure described
in Chapter 4.
Prior to experimental runs the assembled dual inlet platelet function
devices were coated with Von Willebrand Factor at a concentrations of
100µg/mL in Phosphate Buffer Solution (PBS). The flow chamber was in-
cubated for two hours at room temperature and subsequently blocked using
a 1% Bovine Serum Albumin (BSA) solution for one hour. The chamber
was then washed by perfusion using PBS. The intermediate step of block-
ing with BSA ensures platelet activation is caused only the VWF bound
to the surface and any potentially exposed glass does not contribute to the
observed experimental results.
In parallel to chip preparation, whole human blood was drawn, using
a 19 gauge needle from the antecubital vein of healthy donors who were
not known to have taken any medication within the previous 10 days. The
first 5mL of blood collected was routinely discarded to prevent any possible
activation of platelets, and blood was drawn into a clean polypropylene
syringe containing trisodium citrate as anticoagulant (final concentration of
0.32%, 1:9 ratio of citrate to blood). In the case of ReoPro-treated whole
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blood, ReoPro (20 µg/mL in whole blood; Eli Lilly & Co., Indianapolis,
USA) was added to the whole blood sample 20 min prior to experimental
analysis. For fluorescence imaging of platelets, both whole blood samples
were labelled with 3,3’-dihexyloxacarbocyanine iodide (DiOC6(3)) (1 µM;
Invitrogen USA), a fluorescent dye commonly used for platelet function
studies. The labelling was carried out by addition and gentle mixing by
inversion followed by incubation for 10 min prior to experimental analysis
at 37 .
Once the dual inlet platelet device and whole blood have been prepared
as described, the device is placed inside the heated chip holder as previ-
ously shown in Figure 5.15 and the outlet port is plumbed to the pump via
a syringe of Phosphate Buffer Solution (PBS) using 1/16’ inner diameter
SilasticTM tubing via 1/16’ threaded polypropylene connectors attached to
the device buffer inlet and outlet ports.
In a similar manner the buffer inlet port of the device is plumbed to
the pump via a syringe containing the chosen buffer solution. In order
to minimise diffusion effects and viscosity mismatch between whole blood
samples and buffer solution, Histopaque was chosen as a buffer. Histopaque
is a biocompatible reagent with a measured viscosity of 0.004 Pa.s.
As in the case of the experimental procedure used for the single inlet
single outlet device, whole blood samples were assayed at a wall shear force
(stress) of 6 N/m2, which, assuming constant blood viscosity of 0.004 Pa.s
(4 cP), occurs at a volumetric flow rate through the device of 0.6 mL/min.
To this end, the outlet port of the dual inlet device was plumbed to a
syringe and a negative pressure applied to generate 0.6 mL/min volume
flowrate through the main channel of the device thus ensuring the desired
shear stress was generated along the main detection area. The buffer inlet
volume flow rate on the other hand was plumbed to an additional syringe
pump and a positive buffer volume flowrate of 0.575 mL/min was applied.
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This buffer volume flow rate resulted in a whole blood sample consumption
of 25 µL/min and was also above the minimum sample flow rate of 0.5688
mL/min as determined by the fluid model detailed in Chapter 5.
For each experiment, 600 images (350 pixels x 350 pixels) were recorded
at a capture rate of approximately 4.9 frames/s, corresponding to an over-
all run time of just over 120 seconds; in that time, a total blood volume of
just over 50 µL was consumed. In comparison to the existing commercial
system, wherein 5 mL would have been consumed under the same shear
force conditions, and also the single inlet single outlet device wherein ≈150
µL would have been consumed under the same shear force conditions, this
represents a significant reduction in the sample volume required. Although
the reduction in sample volume required from single inlet-single outlet de-
vice to dual inlet device is just over 67% its also worth remembering that
in the case of the dual inlet device this required sample can be delivered to
the device without the need for extraneous reservoirs and tubing containing
additional sample. In the case of our experiments, ≈ 200 µL of whole blood
was pipetted into the sample reservoir of the chip and this sample volume
represented the entire sample volume required to carry out our experiments.
In order to minimise photobleaching effects seen with the commercial
system, the excitation light source was deliberately switched off at regular
periods of the flow run for periods of 5-30 seconds. This allowed a visible
trend in surface coverage of platelets over time to develop while also serving
to minimise the light incident on the platelets thus reducing the effect of
photobleaching.
As before, ten experiments were carried out. Of these ten, five samples
were treated with ReoPro and five remained minimally treated as described
(DiOC6(3) and trisodium citrate as anticoagulant). The captured images
from each experimental flow run performed, as described, were then passed
to a PC for investigations into the effect of ReoPro on whole blood.
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6.3 Analysis
6.3.1 Image Analysis
As with the case of the experimental procedure, the image and data analysis
of shear-mediated, platelet-surface interactions for the dual-inlet device also
followed the same procedure, where possible, as the image and data analysis
for the single inlet-single outlet device. Since the total analysis (image
and data analysis) was based on pixel coverage and pixel distribution, the
analysis software developed could be utilised almost unchanged∗. Indeed the
software could be utilised to operate with any given, appropriately named,
image sequence in any of the common image formats typically used.
6.3.2 Data Analysis
In terms of data analysis, since the data analysis was based on spread-sheet
analysis, as opposed to dependence on pixels numbers, data transfer rates
etc., the same procedures were applied to analysing the data from the dual
inlet platelet function device from the bench-top readout system as was used
for the single inlet-single outlet device from the commercial system. The
main practical difference was in plotting the surface coverage data based
on a different frame rate than the commercial system and, in the case of
plotting size distribution, the selection of frames to take the distribution of
platelet aggregate sizes over. Both these changes were frame-rate based and
in no way altered the analysis principle for both systems. The reduction
∗The principle of analysis remained exactly the same. The main difference concerned
the time stamping of each image. Since the frame rate was approximately 4.9 fps as
opposed to 24fps, each image was time stamped with a capture time accurate to 4
decimal places. This time of capture data was then incorporated into the percentage
change in surface coverage data to give an accurate portrayal of changes in detected
percentage coverage over time
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in frame rate for the bench-top system was implemented as a result of the
decision to change to a larger field of view size for the benchtop system in
order to get a more representative field of view over which to characterise
platelet surface interactions. The change from 256 x 256 pixels, in the case of
the commercial microscope to, 350 x 350 pixels, in the case of the benchtop
system resulted in an increase of analysis area of approximately 87%. This
relatively minor changes in conjunction with the hardware limitations of the
benchtop system (e.g the images were sent from the camera to the laptop
via Firewire connection rather than high speed data bus) resulted in the
software capturing 600 images over a 120 second period. It was felt this
number of images would be sufficient to give a representative analysis of
changes in surface coverage over time.
6.4 Results
The graphs in Figure 6.1 show the resulting plots of detected changes in
surface coverage over time. Figure 6.1(a) shows the detected surface cov-
erage response for untreated whole blood while Figure 6.1(b) shows the
detected surface for reopro treated whole blood. The results correlate well
with the existing experimental data showing an overall increase in surface
coverage over 120 seconds for the untreated whole blood sample while show-
ing an initial increase followed by decrease for ReoPro-treated whole blood
samples.
The graphs have an appreciable noise level compared to the commercial
system. The increase in noise can be explained by a number of factors
primarily associated with the camera selection and imaging optics. Of all
the components included in the bench-top device, the camera and imaging
optics represented the main deviation in terms of hardware quality from the
commercial laboratory experimental configuration. Translating from a high
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(a)
(b)
Figure 6.1: Plots showing changes in surface coverage on VWF through the
dual inlet chip of untreated (a) and ReoPro treated (b) whole blood
speed, liquid cooled camera using expensive oil based microscope optics to
a low cost objective, imaging onto a non-cooled CCD camera reduces image
quality and introduces thermal, electrical and potentially vibrational noise
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into the system. However, despite the increase in noise there still remains
obvious differences between ReoPro and non ReoPro-treated whole blood
samples. Plotting the data from both, commercial and miniaturised systems
side by side, as shown in Figure 6.2, we see strong correlations in changes
in surface coverage over time for both treated and untreated whole blood.
(a) (b)
(c) (d)
Figure 6.2: Comparison of surface coverage data taken from ReoPro treated
and untreated whole blood from the single inlet-single outlet platform ((b)
and (d)) taken using the commercial system and also from the dual inlet
platform ((a) and (c)) obtained from the bench-top device.
In the case of the untreated blood samples the surface coverage increases
in a linear fashion over the experimental flow run while in the case of the
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ReoPro-treated samples there is an initial increase in detected surface cov-
erage followed by an apparent decrease after ≈ 60 seconds. This difference
between ReoPro and non ReoPro-treated whole blood is consistent across
the commercial system, using the single inlet-single outlet device and the
miniaturised bench-top system, using the dual inlet device thus validat-
ing both the dual inlet device and bench-top system as a viable means to
investigate platelet function under shear.
Figure 6.3: Plot of average detected changes in surface coverage through
dual inlet chip. Inset histogram of average detected coverage taken at 115
seconds
As before this surface coverage data can be further visualised by plot-
ting the average surface coverage over the each of the five ReoPro treated
and untreated experimental flow runs as shown in Figure 6.3. The inset bar
graph reveals an average surface coverage for untreated blood of approxi-
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mately 26% and an average surface coverage of approximately 14% in the
case of ReoPro-treated blood. These figures correlate well with the figures
from the single inlet-single outlet device on the commercial chip (approxi-
mately 27% coverage in the case of untreated blood and approximately 16%
in the case of ReoPro treated blood).
Figure 6.4: Plot of average detected changes in surface coverage of platelets
on VWF for both the dual inlet diagnostic on the benchtop readout system
(shown left) and single inlet diagnostic on commercial microscopy system
(shown right). Note the X axis in the case of the commercial system has
been re plotted in seconds, for comparision.
This average surface coverage data can be further visualised in compar-
ison to the commercial system if both graphs are shown side by side as
shown in Figure 6.4. Although, as in the case of the individual plots, the
data from the bench-top device has an appreciably higher noise level than
the commercial system, the similarities between both systems are evident.
In both cases, one observes, in the case of non ReoPro treated blood, an
almost linear increase for the first 120 seconds reaching a surface coverage
of approximately 27.5 %. In the case of the ReoPro-treated blood however,
there is a similar linear increase for approx. 60 seconds or up to a detected
surface coverage of approximately 22% followed by a decrease in detected
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coverage over the remaining 60 seconds to approximately 14%.
In relation to the noise, the development of the bench-top detection sys-
tem resulted in necessary compromises to be made to facilitate the ability
to develop a low cost readout system with a significantly lower overall foot-
print than the commercial systems in order to encourage the entire platelet
function analysis system to be implemented outside specialised facilities.
6.4.1 Platelet Aggregation
In the case of platelet aggregation analysis, a selection of 10 images (frame
numbers 575 - 585) were taken as a representative snapshot of surface cov-
erage at a given time. A snapshot of 10 images would give information for
just over 2 seconds of data while also allowing some noise to be averaged
out of the system. As in the case of the single inlet-single outlet device, the
area of every detected particle in each of the 10 images was then recorded
and a mean particle size and standard error recorded. The average particle
sizes for each flow run can be seen in Figure 6.5
As in the case of the data analysis from the commercial system (See
Chapter 4) the ReoPro treated sample data from the dual inlet chip on the
bench-top device has a significantly lower mean particle size and smaller
standard error than the untreated sample. As previously described, since
ReoPro inhibits fibrinogen-mediated platelet-platelet binding via receptor
αIIbβ3 this in turn inhibits the formation of platelet aggregates on the
surface. In contrast the mean detected particle size for the untreated sam-
ple is significantly greater than in the case of the ReoPro-treated sample
indicating larger platelet aggregate.
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Figure 6.5: Average platelet aggregate distributions on treated and un-
treated samples using the dual inlet device on the bench-top system
6.5 Conclusions
The functionality of the entirely new platelet function analysis system was
demonstrated and results compared favourably to the commercial readout
system.
In terms of chip performance, the dual inlet chip resulted in a 67%
reduction in required sample volume from the single inlet single outlet de-
vice. It is worth remembering that the single inlet-single outlet device itself
represented a greater than >97% reduction in sample volume over exist-
ing commercial parallel plate flow devices. While the reduction in volume
from the single inlet-single outlet device to dual inlet device is significant,
the design of the dual inlet device is such that any additional dead volume
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requirements are eliminated. This feature facilitates a significant devia-
tion from standard parallel plate devices in terms of sample loading and
can potentially be incorporated with a finger stick type approach to blood
sampling as opposed to the relatively intrusive blood draw via syringe.
In terms of readout system performance, while there was an apprecia-
ble noise level associated with the bench top device the results compared
favourably with the commercial, large scale, readout system. The noise re-
sulted from design compromises made during readout system development
as discussed, and design constraints such as cost and overall readout system
size were central to any design decisions. The ability to develop a low cost,
bench-top device for platelet function analysis was of paramount impor-
tance in the readout system development. Nonetheless, the data from the
bench-top readout system correlated extremely well with data using high
speed image capture on a commercial microscope. In the case of average
data analysis as shown in Figure 6.4, both ReoPro-treated blood and non
ReoPro-treated blood could readily be discerned by its distinctive profile
from either bench-top readout system or commercial system.
In short, an entirely novel approach to parallel plate type devices for
shear-mediated platelet function analysis has been validated. This approach
requires a total sample volume of <200 µL for a 120 second experimental
flow run at a shear rate of 1500 s−1. Further, the device has been tested
on a miniaturised, user friendly, low cost, readout system for platelet func-
tion analysis and results compare favourably with large scale, commercial
systems.
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Conclusions
The exploitation of microscale fluid dynamic effects coupled with a relatively
unique approach to BioMEMS fabrication, facilitated the development of
a platelet function test platform capable of delivering relevant diagnostic
information relating to platelet function under shear flow from a whole
blood sample.
The objectives of this work as described in Chapter 1 were realised.
1. To design a robust platform to characterise platelet-surface interac-
tions in whole blood under vascular shear rates in response to VWF.
A variation on existing commercial parallel plate devices was devel-
oped based on fluid flow equations governing flow through a rectangu-
lar duct. This device resulted in a >95% reduction in required sample
volume flow rate for an arterial shear rate of 1500 s−1. Further the
device proved to be significantly more user friendly than existing par-
allel plate devices based on its disposable nature. It also resulted in
the elimination of the need for an external vacuum pump to facili-
tate sealing of the device. The glass surface of the device was coated
with Von Willebrand Factor, a protein prevalent in the initial stages
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of platelet activation, and fluorescently labelled whole human blood
was passed through the device at a shear rate of 1500 −1.
2. To develop an algorithm to objectively quantify platelet-surface inter-
actions in whole blood under physiologically relevant shear rates.
An image processing algorithm was developed based on the detection
of areas of high intensity corresponding to areas of platelet interaction.
Each of these areas of high intensity were recorded, thereby facilitating
a calculation of the overall surface coverage for a given image. This
process was repeated for each captured image and a profile of changes
in surface coverage was generated. This was further validated by the
deliberate addition of an anti-platelet drug and differences in changes
of surface coverage were observed. Further, the software also facili-
tated size distribution of areas of high intensity corresponding to the
degree of platelet-platelet aggregation.
3. To utilise developments in the area of BioMEMS to significantly re-
duce the sample volume required for an experimental run.
A significant deviation from the traditional parallel plate type of de-
vices was developed. Using a variation of the well established hy-
drodynamic focussing technique, a new platelet function device was
developed. This device shapes the fluid and ensures contact with
the imaging/protein coated surface. This design represented a further
reduction in sample volume requirements, eliminated sample dead vol-
ume and allowed the end user to vary the wall shear force independent
of sample volume consumption.
4. To develop an integrated low cost miniaturised detection system, incor-
porating all fundamental aspects of existing laboratory detection sys-
tems.
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To test the new platelet function device a dedicated readout system
was developed. This readout system was primarily aimed at mak-
ing platelet function tests more accessible to the general public. As
such, the readout system design requirements meant that the sys-
tem should be low cost and represent significantly more integration
than existing detection systems while also being significantly smaller
in overall size. The developed system was a bench-top device incorpo-
rating epi-fluorescence microscopy, thermal control of the chip holding
stage, two independent fluid delivery modules all connected to a laptop
computer with a single software interface. The laptop also incorpo-
rated the post experiment custom image analysis software. On testing
the new platelet function device on the bench-top system under the
same experimental conditions, the results were found to compare very
favourably with the commercial system and original platelet function
chip.
In all, an inexpensive, shear-mediated, platelet function analysis under
flow system has been developed. The sample volumes required represent a
significant reduction in comparison to existing parallel plate type devices.A
time-based metric of surface coverage has been developed and successfully
demonstrated against a commercially available anti platelet therapy.
7.0.1 Future Work
Although the overall system has been shown to compare favourably to com-
mercial devices, futher developments could improve overall functionality of
the system. These developments should come under the following headings.
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Engineering improvements
A reduction in noise from the system would be of obvious benefit. This
could be obtained from a hardware perspective by;
 introducing extraneous optics to improve signal quality.
 reduce the effect of background light where possible
 further optimisation of cameras settings
 a reduction in external vibration effects
In terms of software improvements, more in-depth image processing
could potentially improve image quality and the further improvement of
a threshold algorithm to specifically identify platelets from a given image
would reduce any potential photo-bleaching effects.
End use improvements
From an end use of patient perspective the next step in development should
be to the transition from traditional blood draw analysis to finger stick
approach to sample delivery. This transition is not without complications.
Most traditional parallel plate assays use fluorescently labelled and anti
coagulated blood. While the addition of the finger stick approach could
eliminate the requirement for the addition of anti-coagulants, this in turn
could potentially alter resulting data for ’normal’ and abnormal blood sam-
ples. However the elimination of the addition of anti-coagulant was outlined
as highly desirable in the recent communication by International Society on
Thrombosis and Haemostasis [1] and a finger stick sampling approach fa-
cilitated by the dual inlet approach to parallel plate flow chambers is a
significant step to realising this goal. More technically challenging per-
haps is the requirement for the addition of the fluorescent stain to visualise
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platelets in whole blood. Potential solutions would be coating the sample
reservoir in the fluorescent stain and allowing the dye to re-dissolve through
the sample before allowing the sample flow through the chamber. Perhaps
a more attractive option would be to use a dissolvable film over the sample
reservoir. This film could be doped with appropriate concentrations of the
fluorescent stain and would dissolve upon contact with whole blood. The
dissolution rate of the film could be tuned to ensure appropriate mixing of
both dye and whole blood sample. Further, the film would act to prevent
the sample channel from being exposed to the environment prior to addition
of a whole blood sample.
Diagnostic development
Although the device was validated using the shear-mediated whole blood
response to VWF there is no limitation, in principle, to further investiga-
tions using alternative proteins of interest. The nature of the device makes
using various types of collagen or fibrinogen over various concentrations a
valid and viable option. Naturally, depending on the metric of interest,
changes made be required to the analysis technique. Nonetheless the device
and readout system would remain suited to imaging and recording platelet-
surface interactions in whole blood in response to various protein agonists
to study the efficacy of the multitude of anti-platelet therapies.
141
Bibliography
[1] JJ Zwagina, KS Sakariassen, MR King, TG Diacovo, EF Grabowski,
G. Nash, M. Hoylaerts, and JWM Heemskerk. Can blood flow assays
help to identify clinically relevant differences in von Willebrand factor
functionality in von Willebrand disease types 1-3? 1. Journal of Throm-
bosis and Haemostasis, 5(12):2547–2549, 2007.
142
Selected Publications
Patents:
 Nigel J. Kent, Bryan Lincoln, Lourdes Basabe Desmonts, Antonio J. Ricco,
Dermot Kenny, Gerardene Meade, Brian G. Corcoran. Microfluidic De-
vice for Assessing Cell Surface Interactions. United Kingdom Patent
Application No. 0802084.4 - Currently filed
Peer reviewed:
 Aoife Morrin, Orawan Ngamnac, Eimer O Malley, Nigel Kent, Simon E.
Moulton, Gordon G. Wallace, Malcolm R. Smyth, Anthony J. Killard.
The fabrication and characterization of inkjet-printed polyaniline
nanoparticle films. Electrochimica Acta 53 (2008) 5092 - 5099
 Fu-Qiang Nie, Mirek Macka, Leon Barron, Damian Connolly, Nigel Kent
and Brett Paull. Robust monolithic silica-based on-chip electro-
osmotic micro-pump. Analyst, 2007, 132, 417
 William G. Holthoff, Elizabeth C. Tehan, Rachel M. Bukowski, Nigel Kent,
Brian D. MacCraith and Frank V. Bright. Radio luminescent Light
Source for the development of Optical Sensor Arrays. Anal. Chem.2005,
77,718-72
 R. Blue, N. Kent, L. Polerecky, H. McEvoy, D. Gray, and B.D. MacCraith.
Platform for enhanced detection efficiency in luminescence-based
143
BIBLIOGRAPHY N.J.Kent
sensors. Electronics Letters – 9 June 2005 – Volume 41, Issue 12, p. 682-
684
 Eadaoin Tyrrell, Ceri Gibson, Brian D. MacCraith, David Gray, Pat Byrne,
Nigel Kent, Conor Burke and Brett Paull. Development of a micro-
fluidic manifold for copper monitoring utilising chemilumines-
cence detection. Lab on a Chip, 2004, 4(4), 384 - 390
Non Peer Reviewed
 A. Ricco, N. Kent, G. Meade, B. Lincoln, L. Basabe Desmonts, B. Mac-
Craith, B. Corcoran and D. Kenny Whole-Blood Diagnostic Sens-
ing System Based on Populational Platelet Rolling Behavior215th
Electro Chemical Society Meeting. May 09
 A. Ricco, N. Kent, G. Meade, B. Lincoln, L. Basabe Desmonts, B. Mac-
Craith, B. Corcoran and D. Kenny Microfluidic System for Whole-
Blood Diagnostic Analysis of Populational Platelet Rolling Be-
havior 41st Annual Oak Ridge Conference. April 09
 N. J. Kent, B. O’Reilly, B D MacCraith, B Corcoran. Low cost manu-
facturing technique for hybrid microfluidic platforms. International
Manufacturing Conference - Waterford. August 2007
 M. Tweedie, R. Subramanian, P.Lemoine, N. Kent, I. Craig, E.T. McAdams,
J.A. McLaughlin, B. MacCraith. Fabrication of impedimetric sen-
sors for label-free Point-of-Care immunoassay cardiac marker sys-
tems, with passive microfluidic delivery. Proceedings of IEEE 2006
International Conference of the Engineering in Medicine and Biology Soci-
ety
 McEvoy, Helen M.; Blue, Robert; Kent, Nigel; Polerecky, Lubos; McDon-
agh, Colette; MacCraith, Brian D. Novel polymer platform for en-
144
BIBLIOGRAPHY N.J.Kent
hanced biochip performance. Proceedings of SPIE-The International
Society for Optical Engineering (2005)
 Eadaoin Tyrrell, Ceri Gibson, Brian MacCraith, David Gray, Nigel Kent
and Brett Paull. Development of a microfluidic based analytical
system for copper monitoring in environmental sample matrices.
Research and Development Topics, 21-JUL-03 - 23-JUL-03, University of
Sunderland
 Eadaoin Tyrrell, Ceri Gibson, Brian MacCraith, Nigel Kent and Brett
Paull. Development of a microfluidic based analytical system for
copper monitoring in environmental samples RSC Analytical Re-
search Forum 2004, 19-JUL-04 - 21-JUL-04, University of Central Lan-
cashire, Preston, UK
 Nigel J. Kent, Geradene Meade, Lourdes Basabe-Desmonts, Bryan Lincoln,
Antonio J. Ricco, Dermot Kenny,Brian D. MacCraith, Brian G. Corcoran.
Development of a Microfluidic Platform and Detection System
for Platelet Function Analysis.12th International Conference on Minia-
turized Systems for Chemistry and Life Sciences (µTAS2008), San Diego,
USA, October 12-16, 2008:1048-1050.
 B Lincoln, G Meade, N.J. Kent, L Basabe-Desmonts, D Kenny, A.J. Ricco,
and L.P. Lee. Analysis of Whole Blood Platelet Translocation on
a VWF-Coated Microfluidic Flow Chamber. 12th International Con-
ference on Miniaturized Systems for Chemistry and Life Sciences (µTAS2008),
San Diego, USA, October 12-16, 2008:453-455.
 Nigel J. Kent, Geradene Meade, Lourdes Basabe-Desmonts, Bryan Lin-
coln, Antonio J. Ricco, Dermot Kenny, Brian D. MacCraith, Brian G.
Corcoran.Development of a Microfluidic Platform and Detection
System for Platelet Function Analysis Europtrode IX - Dublin March
30th April 2nd, 2008.
145
BIBLIOGRAPHY N.J.Kent
 R Blue, N Kent, H McEvoy, S Hearty, R O’Kennedy. B MacCraith De-
velopment of Optical Biochip Arrays for Cardiac Markers Cross-
Border Programme for Research and Education Contributing to Peace and
Reconciliation April 2006.
 M. Tweedie, R. Subramanian, I. Craig, E.T. McAdams, J.A. McLaugh-
lin, B. MacCraith, R. O’Kennedy, N. Kent S. Hearty Impedimetric Mi-
crofluidic Point of Care Sensors with RF data transmission Cross-
Border Programme for Research and Education Contributing to Peace and
Reconciliation - Showcase Event June 2005
146
Bibliography
[1] Cardiovascular disease: prevention and control.
http://www.who.int/dietphysicalactivity/publications/facts/cvd/en/, page
Last accessed 7th April 2008.
[2] G. Davi and C. Patrono. Platelet Activation and Atherothrombosis. New
England Journal of Medicine, 357(24):2482, 2007.
[3] R. R. Seeley, T. D. Stephens, and P. Tate. Essentials of Anatomy and
Physiology. McGraw-Hill, 2002.
[4] J.N. George. Platelets. The Lancet, 355(9214):1531–1539, 2000.
[5] Alan D. Michelson. Platelets Second Ed. Elsevier Academic Press, 2007.
[6] M. H. Kroll, J. D. Hellums, L. V. McIntire, A. I. Schafer, and J. L. Moake.
Platelets and shear stress. Blood, 88(5):1525–1541, Sep 1 1996.
[7] A. S. Kantak, B. K. Gale, Y. Lvov, and S. A. Jones. Platelet Function
Analyzer: Shear Activation of Platelets in Microchannels. Biomedical Mi-
crodevices, 5(3):207–215, 2003.
[8] R. Ross. Atherosclerosis is an inflammatory disease. American Heart Jour-
nal, 138(5 part 2):S419, 1999.
[9] O.J.T. McCarty, S.A. Mousa, P.F. Bray, and K. Konstantopoulos. Immo-
bilized platelets support human colon carcinoma cell tethering, rolling, and
firm adhesion under dynamic flow conditions. Blood, 96(5):1789, 2000.
147
BIBLIOGRAPHY N.J.Kent
[10] P. Harrison. Platelet function analysis. Blood reviews, 19(2):111–123, Mar
2005.
[11] A.D. Michelson. Platelet Function Testing in Cardiovascular Diseases, 2004.
[12] Brown, David and Larson, Richard. Improvements to parallel plate flow
chambers to reduce reagent and cellular requirements. BMC Immunology,
2(1):9, 2001.
[13] N.A. Mody, O. Lomakin, T.A. Doggett, T.G. Diacovo, and M.R. King. Me-
chanics of Transient Platelet Adhesion to von Willebrand Factor under Flow.
Biophysical Journal, 88(2):1432–1443, 2005.
[14] JJ Zwagina, KS Sakariassen, MR King, TG Diacovo, EF Grabowski,
G. Nash, M. Hoylaerts, and JWM Heemskerk. Can blood flow assays help
to identify clinically relevant differences in von Willebrand factor function-
ality in von Willebrand disease types 1-3? 1. Journal of Thrombosis and
Haemostasis, 5(12):2547–2549, 2007.
[15] T.H. Schulte, R.L. Bardell, and B.H. Weigl. Microfluidic technologies in
clinical diagnostics. Clinica Chimica Acta, 321(1-2):1–10, 2002.
[16] E. Verpoorte. Microfluidic chips for clinical and forensic analysis. Elec-
trophoresis, 23(5), 2002.
[17] DA Beebe. Folch,The Science and Applications of Cell Biology in Microsys-
tems,. Lab on a Chip, 5:10–11, 2005.
[18] S. D. Minteer. Microfluidic techniques. Humana Press, 2006.
[19] NT Nguyen and ST Wereley. Fundamentals and Applications of Microflu-
idics. Artech House, 2002.
[20] P.J. Hung, P.J. Lee, P. Sabounchi, R. Lin, and L.P. Lee. Continuous per-
fusion microfluidic cell culture array for high-throughput cell-based assays.
Biotechnology and Bioengineering, 89(1):1–8, 2005.
148
BIBLIOGRAPHY N.J.Kent
[21] S.W. Rhee, A.M. Taylor, C.H. Tu, D.H. Cribbs, C.W. Cotman, and N.L.
Jeon. Patterned cell culture inside microfluidic devices. Lab on a Chip,
5(1):102–107, 2005.
[22] A. Tourovskaia, X. Figueroa-Masot, and A. Folch. Differentiation-on-a-chip:
A microfluidic platform for long-term cell culture studies. Lab on a Chip,
5(1):14–19, 2005.
[23] W.C. Chang, L.P. Lee, and D. Liepmann. Biomimetic technique for
adhesion-based collection and separation of cells in a microfluidic channel.
Lab on a Chip, 5(1):64–73, 2005.
[24] A. Revzin, K. Sekine, A. Sin, R.G. Tompkins, and M. Toner. Development
of a microfabricated cytometry platform for characterization and sorting of
individual leukocytes. Lab on a Chip, 5(1):30–37, 2005.
[25] A. Bonnefoy, Q. Liu, C. Legrand, and M. M. Frojmovic. Efficiency of platelet
adhesion to fibrinogen depends on both cell activation and flow. Biophysical
journal, 78(6):2834–2843, Jun 2000.
[26] Y. Ikeda, M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo,
Y. Kawai, K. Watanabe, and I. Itagaki. The role of von Willebrand factor
and fibrinogen in platelet aggregation under varying shear stress. The Jour-
nal of clinical investigation, 87(4):1234–1240, Apr 1991.
[27] H. Lu, L. Y. Koo, W. M. Wang, D. A. Lauffenburger, L. G. Griffith, and
K. F. Jensen. Microfluidic shear devices for quantitative analysis of cell
adhesion. Analytical Chemistry, 76(18):5257–5264, Sep 15 2004.
[28] N. A. Mody, O. Lomakin, T. A. Doggett, T. G. Diacovo, and M. R. King.
Mechanics of transient platelet adhesion to von Willebrand factor under flow.
Biophysical journal, 88(2):1432–1443, Feb 2005.
[29] M. Bahrami, MM Yovanovich, and JR Culham. PRESSURE DROP OF
FULLY-DEVELOPED, LAMINAR FLOW IN MICROCHANNELS OF
149
BIBLIOGRAPHY N.J.Kent
ARBITRARY CROSS-SECTION. Proceedings of 3rd international confer-
ence on microchannels and minichannels, Toronto, Canada, 2005.
[30] DP Bakker, A. van der Plaats, GJ Verkerke, HJ Busscher, and HC van der
Mei. Comparison of Velocity Profiles for Different Flow Chamber Designs
Used in Studies of Microbial Adhesion to Surfaces. Applied and Environ-
mental Microbiology, 69(10):6280–6287, 2003.
[31] I. Papautsky, B. K. Gale, S. Mohanty, T. A. Ameel, and A. B. Frazier.
Effects of rectangular microchannel aspect ratio on laminar friction con-
stant. Proceedings of SPIE-The International Society for Optical Engineer-
ing, Proceedings of the 1999 Microfluidic Devices and Systems II, Santa
Clara, 3877:147–158, 1999.
[32] James B. Knight, Ashvin Vishwanath, James P. Brody, and Robert H.
Austin. Hydrodynamic Focusing on a Silicon Chip: Mixing Nanoliters in
Microseconds. Physical Review Letters, 80(17):3863, 04/27/ 1998.
[33] Gwo-Bin Lee, Chen-I Hung, Bin-Jo Ke, Guan-Ruey Huang, Bao-Herng
Hwei, and Hui-Fang Lai. Hydrodynamic Focusing for a Micromachined Flow
Cytometer. Journal of Fluids Engineering, 123(3):672–679, 2001.
[34] R. Miyake, H. Ohki, I. Yamazaki, and R. Yabe. A development of micro
sheath flow chamber. Micro Electro Mechanical Systems, 1991, MEMS’91,
Proceedings.’An Investigation of Micro Structures, Sensors, Actuators, Ma-
chines and Robots’.IEEE, pages 265–270, 1991.
[35] Z. Wu and N. T. Nguyen. Hydrodynamic focusing in microchannels under
consideration of diffusive dispersion: theories and experiments. Sensors and
Actuators B, 107(2):965–974, 2005.
[36] Gwo-Bin Lee, Bao-Herng Hwei, and Guan-Ruey Huang. Micromachined pre-
focused MN flow switches for continuous multi-sample injection. Journal of
Micromechanics and Microengineering, 11(6):654–661, 2001.
150
BIBLIOGRAPHY N.J.Kent
[37] S. Chung, S. J. Park, J. K. Kim, C. Chung, D. C. Han, and J. K. ER .
Chang. Plastic microchip flow cytometer based on 2- and 3-dimensional
hydrodynamic flow focusing. Microsystem Technologies, 9(8):525–533, 10//
2003.
[38] Anne Y. Fu, Charles Spence, Axel Scherer, Frances H. Arnold, and
Stephen R. Quake. A microfabricated fluorescence-activated cell sorter.
Nat Biotech, 17(11):1109–1111, 11//print 1999. M3: 10.1038/15095;
10.1038/15095.
[39] S.A. Wang, W. Soper. Bio-MEMS Technologies and Applications. CRC
Press, 2007.
[40] H. Becker and C. Gartner. Polymer microfabrication methods for microflu-
idic analytical applications. Electrophoresis, 21(1):12–26, 2000.
[41] H. Klank, J.P. Kutter, and O. Geschke. CO 2-laser micromachining and
back-end processing for rapid production of PMMA-based microfluidic sys-
tems. Lab on a Chip, 2(4):242–246, 2002.
[42] E´. Tyrrell, C. Gibson, B.D. MacCraith, D. Gray, P. Byrne, N. Kent,
C. Burke, and B. Paull. Development of a micro-fluidic manifold for copper
monitoring utilising chemiluminescence detection. Lab on a Chip, 4(4):384–
390, 2004.
[43] R. Blue, N. Kent, L. Polerecky, H. McEvoy, D. Gray, and BD MacCraith.
Platform for enhanced detection efficiency in luminescence-based sensors.
Electronics Letters, 41(12):682–684, 2005.
[44] Y. Xia and G.M. Whitesides. Soft lithography. Angew. Chem. Int. Ed,
37(5):550–575, 1998.
[45] M.L. Chabinyc, D.T. Chiu, J.C. McDonald, A.D. Stroock, J.F. Christian,
A.M. Karger, and G.M. Whitesides. An integrated fluorescence detection
151
BIBLIOGRAPHY N.J.Kent
system in poly (dimethylsiloxane) for microfluidic applications. Analytical
Chemistry, 73:4491–4498, 2001.
[46] J.R. Anderson, D.T. Chiu, R.J. Jackman, O. Cherniavskaya, J.C. McDonald,
H. Wu, S.H. Whitesides, and G.M. Whitesides. Fabrication of topologically
complex three-dimensional microfluidic systems in PDMS by rapid proto-
typing. Analytical Chemistry, 72:3158–3164, 2000.
[47] M.A. Unger, H.P. Chou, T. Thorsen, A. Scherer, and S.R. Quake. Monolithic
Microfabricated Valves and Pumps by Multilayer Soft Lithography. Science,
288(5463):113–116, 2000.
[48] N. Chronis, G. Liu, K.H. Jeong, and L. Lee. Tunable liquid-filled microlens
array integrated with microfluidic network. Optics Express, 11(19):2370–
2378, 2003.
[49] W.H. Grover, A.M. Skelley, C.N. Liu, E.T. Lagally, and R.A. Mathies. Mono-
lithic membrane valves and diaphragm pumps for practical large-scale inte-
gration into glass microfluidic devices. Sensors & Actuators: B. Chemical,
89(3):315–323, 2003.
[50] JM Berg, R. Anderson, M. Anaya, B. Lahlouh, M. Holtz, and T. Dallas. A
two-stage discrete peristaltic micropump. Sensors & Actuators: A. Physical,
104(1):6–10, 2003.
[51] T.J. Johnson, E.A. Waddell, G.W. Kramer, and L.E. Locascio. Chemi-
cal mapping of hot-embossed and UV-laser-ablated microchannels in poly
(methyl methacrylate) using carboxylate specific fluorescent probes. Applied
Surface Science, 181(1-2):149–159, 2001.
[52] H. Becker, W. Dietz, P. Dannberg, and G. Jena. MICROFLUIDIC MANI-
FOLDS BY POLYMER HOT EMBOSSING FOR µTAS APPLICATIONS.
Micro Total Analysis Systems’ 98: Proceedings of the [Mu] TAS’98 Work-
shop, Held in Banff, Canada, 13-16 October 1998, 1998.
152
BIBLIOGRAPHY N.J.Kent
[53] H. Becker and U. Heim. Hot embossing as a method for the fabrication of
polymer high aspect ratio structures. Sensors & Actuators: A. Physical,
83(1-3):130–135, 2000.
[54] K. Ueno, F. Kitagawa, H.B. Kim, T. Tokunaga, S. Matsuo, H. Misawa,
and N. Kitamura. Fabrication and Characteristic Responses of Integrated
Microelectrodes in Polymer Channel Chip. Chemistry Letters, 29(8):858–
859, 2000.
[55] SA Soper, SM Ford, S. Qi, RL McCarley, K. Kelly, and MC Murphy.
Polymeric microelectromechanical systems. Anal Chem, 72(19):642A–651A,
2000.
[56] M.A. Roberts, J.S. Rossier, P. Bercier, and H. Girault. UV Laser Machined
Polymer Substrates for the Development of Microdiagnostic Systems. Sci-
ence, 261:895–897, 1993.
[57] D. Snakenborg, H. Klank, and J.P. Kutter. Microstructure Fabrication with
a CO 2 Laser System. Journal of Micromechanics and Microengineering,
14(2):182–189, 2004.
[58] M. Bowden, O. Geschke, J.P. Kutter, and D. Diamond. CO2 laser micro-
fabrication of an integrated microfluidic manifold for application in environ-
mental monitoring. Lab-on-a-Chip, 3(4):221–223, 2003.
[59] R.M. McCormick, R.J. Nelson, M.G. Alonso-Amigo, D.J. Benvegnu, and
H.H. Hooper. Microchannel electrophoretic separations of DNA in injection-
molded plastic substrates. Anal. Chem, 69(14):2626–2630, 1997.
[60] G.J. Kellogg, T.E. Arnoldt, B.L. Carvalho, D.C. Dulfy, and N.F. Shep-
pard Jr. Centrifugal Microfluidics: Applications. Micro Total Analysis Sys-
tems 2000: Proceedings of the [Mu] Tas 2000 Symposium, Held in Enschede,
the Netherlands, 14-18 May 2000, 2000.
153
BIBLIOGRAPHY N.J.Kent
[61] N. Thomas, A. Ocklind, I. Blikstad, S. Griffiths, M. Kenrick, H. Derand,
G. Ekstrand, C. Ellstro¨m, A. Larsson, and P. Andersson. Integrated cell
based assays in microfabricated disposable CD devices. Micro Total Analysis
Systems 2000: Proceedings of the TAS 2000 Symposium, pages 249–252,
2000.
[62] T. Brenner, T. Glatzel, R. Zengerle, and J. Ducre´e. Frequency-dependent
transversal flow control in centrifugal microfluidics. Lab on a Chip, 5(2):146–
150, 2005.
[63] B.H. Weigl, J. Kriebel, K.J. Mayes, T. Bui, and P. Yager. Whole Blood
Diagnostics in Standard Gravity and Microgravity by Use of Microfluidic
Structures (T-Sensors). Microchimica Acta, 131(1):75–83, 1999.
[64] B.H. Weigl, R. Bardell, T. Schulte, F. Battrell, and J. Hayenga. Design
and Rapid Prototyping of Thin-Film Laminate-Based Microfluidic Devices.
Biomedical Microdevices, 3(4):267–274, 2001.
[65] B.H. Weigl, R.L. Bardell, and C.R. Cabrera. Lab-on-a-chip for drug devel-
opment. Advanced Drug Delivery Reviews, 55(3):349–377, 2003.
[66] Fluidics Subsystem for GeneSat Experimental Payload.
http://genesat.arc.nasa.gov/fluidics.html, page Last accessed 7th April
2008.
[67] M.W. Inc.Merriam-Webster’s collegiate dictionary. Merriam-Webster, 2003.
[68] F.M. White. Fluid Mechanics. McGraw-Hill, 2003.
[69] H. Bruus. Theoretical microfluidics. Oxford University Press, USA, 2008.
[70] DA Hammer and SM Apte. Simulation of cell rolling and adhesion on sur-
faces in shear flow: general results and analysis of selectin-mediated neu-
trophil adhesion. Biophysical Journal, 63(1):35–57, 1992.
154
BIBLIOGRAPHY N.J.Kent
[71] P. Tandon and SL Diamond. Hydrodynamic effects and receptor interactions
of platelets and their aggregates in linear shear flow. Biophysical Journal,
73(5):2819–2835, 1997.
[72] A. van den Berg, W. Olthuis, and P. Bergveld. Micro Total Analysis Systems
2000: Proceedings of the [Mu] Tas 2000 Symposium, Held in Enschede, the
Netherlands, 14-18 May 2000. Kluwer Academic Publishers, 2000.
[73] L. Lin, C.J. Chiu, W. Bache, and M. Heckele. Microfabrication using silicon
mold inserts and hot embossing. Micro Machine and Human Science, 1996.,
Proceedings of the Seventh International Symposium, pages 67–71, 1996.
[74] L. Martynova, L.E. Locascio, M. Gaitan, G.W. Kramer, R.G. Christensen,
and W.A. MacCrehan. Fabrication of Plastic Microfluid Channels by Im-
printing Methods. Burns, 144:147.
[75] L. Locasci&, M. Gaitan, J. Hong, and M. Eldefrawi. PLASTIC MI-
CROFLUID DEVICES FOR CLINICAL MEASUREMENTS. Micro Total
Analysis Systems’ 98: Proceedings of the [Mu] TAS’98 Workshop, Held in
Banff, Canada, 13-16 October 1998, 1998.
[76] J. Xu, L. Locascio, M. Gaitan, and C.S. Lee. Room-Temperature Imprinting
Method for Plastic Microchannel Fabrication. Science, 261:895, 1993.
[77] K. UCHIYAMA, W. XU, M. YAMAMOTO, T. SHIMOSAKA, and
T. HOBO. Development of Imprinted Polymer Microchannel Capillary Chip
for Capillary Electrochromatography. Analytical Sciences, 15(9):825–826,
1999.
[78] S. Lazare and R. Srinivasan. Surface properties of poly (ethylene terephtha-
late) films modified by far-ultraviolet radiation at 193nm (laser) and 185nm
(low intensity). The Journal of Physical Chemistry, 90(10):2124–2131, 1986.
155
BIBLIOGRAPHY N.J.Kent
[79] L. Brown, T. Koerner, J.H. Horton, and R.D. Oleschuk. Fabrication and
characterization of poly (methylmethacrylate) microfluidic devices bonded
using surface modifications and solvents. Lab on a Chip, 6(1):66–73, 2006.
[80] J. Li, D. Chen, and G. Chen. Low-Temperature Thermal Bonding of PMMA
Microfluidic Chips. Analytical Letters, 38(7):1127–1136, 2005.
[81] A.M. Lincoff, J.E. Tcheng, R.M. Califf, D.J. Kereiakes, T.A. Kelly, G.C.
Timmis, N.S. Kleiman, J.E. Booth, C. Balog, C.F. Cabot, et al. Sustained
Suppression of Ischemic Complications of Coronary Intervention by Platelet
GP IIb/IIIa Blockade With Abciximab One-Year Outcome in the EPILOG
Trial. Circulation, 99(15):1951–1958, 1999.
[82] S.M. Trivedi, J. Shani, and G. Hollander. Bleeding Complications of Platelet
Glycoprotein IIb/IIIa Inhibitor Abciximab (ReoPro). Journal of Invasive
Cardiology, 14(7):423–425, 2002.
[83] S.D. Berkowitz, R.A. Harrington, M.M. Rund, and J.E. Tcheng. Acute pro-
found thrombocytopenia after C7E3 Fab (abciximab) therapy. Circulation,
95(4):809–813, 1997.
156
Appendices
157
Appendix A
Platelet Function Analysis
Systems
Basis of test Name of Test Advantages Disadvantages
In vivo cessation
of blood flow by
platelet plug
Bleeding time In vivo test;
physiological
Nonspecific;
insensitive; can
leave scar
In vitro
cessation of high
shear blood flow
by platelet plug
PFA-100 Simple, rapid;
low sample
volume; high
shear; minimal
sample
preparation
Dependent on
Von Willebrand
factor and
hematocrit; no
instrument
adjustment
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Basis of test Name of Test Advantages Disadvantages
Shear-induced
platelet
adhesion
IMPACT (cone
and plate (let)
analyzer,
DiaMed)
Simple, rapid;
point-of-care;
low sample
volume; high
shear; whole
blood assay
Instrument not
yet widely
available
Platelet-to-
platelet
aggregation
Aggregometry
(turbidometric)
Historical gold
standard
Poor
reproducibility;
high sample
volume; sample
preparation;
time consuming;
expensive
Platelet-to-
platelet
aggregation
Aggregometry
(impedance)
Whole blood
assay
High sample
volume; sample
preparation;
time consuming;
expensive
Platelet-to-
platelet
aggregation
VerifyNow
(Ultegra RPFA)
Simple, rapid;
point-of-care;
low sample
volume;
No instrument
adjustment
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Basis of test Name of Test Advantages Disadvantages
Platelet-to-
platelet
aggregation
Plateletworks
(Helena
Laboratories)
Minimal sample
preparation;
whole blood
assay
Not well studied
Activation
dependent
changes in
platelet surface
Platelet surface
Platelet surface
P-selectin,
platelet surface
activated GP
IIb/IIIa,
leukocyte-
platelet
aggregates (flow
cytometry)
Low sample
volume; whole
blood assay
Sample
preparation;
expensive;
requires flow
cytometer and
experienced
operator
Activation
dependent
signaling
VASP
phosphorylation
state (flow
cytometry)
Directly
dependent on
clopidogrels
target, P2Y12;
low sample
volume; whole
blood assay
Sample
preparation;
expensive;
requires flow
cytometer and
experienced
technician
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Basis of test Name of Test Advantages Disadvantages
Activation
dependent
release from
platelets
Platelet-derived
microparticles
(flow
cytometry)
Low sample
volume; whole
blood assay
Sample
preparation;
expensive;
requires flow
cytometer and
experienced
technician
Activation
dependent
release from
platelets
Serum
thromboxane B2
Directly
dependent on
aspirins target,
COX-1
Indirect
measure; not
platelet specific
Activation
dependent
release from
platelets
Plasma GPV Platelet specific Separation of
plasma can
result in
artifactual
platelet
activation;
reflects only
thrombin-
mediated
platelet
activation
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Basis of test Name of Test Advantages Disadvantages
Activation
dependent
release from
platelets
α-Granule
constituents in
plasma: platelet
factor 4, β-
thromboglobulin,
soluble
P-selectin
Reflect platelet
secretion
Separation of
plasma can
result in
artifactual
platelet
activation;
plasma soluble
P-selectin also
originates from
endothelial cells
Table A.1: Platelet function Analysis Systems
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Equations of Motion
B.1 Conservation of Mass
Consider the volume in Figure B.1 showing an idealised fixed control volume of
fluid. Since the flow through each side is considered approximately one dimen-
sional the conservation of mass states the change in density of the volume over
the surface plus mass flow in less the mass flow out sums to zero or:∫
Ω
∂ρ
∂t
dV+
∑
i
(ρiAiVi)out −
∑
i
(ρiAiVi)in = 0 (B.1)
Since the volume element is so small the integral reduces to the differential
term:
∫
Ω
∂ρ
∂t
dV ≈ ∂ρ
∂t
dxdydz (B.2)
Since the mass flow acts on all six faces of the control and the the fluid is
assumed to be a continuum we can list all six flows as shown in TableB.2
Substituting these values into eqn B.1 we get:
∂ρ
∂t
dxdydz +
∂
∂x
(ρu)dxdydz +
∂
∂y
(ρv)dxdydz +
∂
∂z
(ρw)dxdydz = 0 (B.3)
The element volume cancels to leave:
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Face Inlet mass flow Outlet mass flow
x ρu dy dz
[
ρu +
∂
∂x (ρu) dx
]
dy dz
y ρv dx dz
[
ρv +
∂
∂y (ρv) dy
]
dx dz
z ρw dx dy
[
ρw +
∂
∂z (ρw) dz
]
dx dy
Table B.1: Mass flow table
Figure B.1: Control volume showing mass flow in x direction
∂ρ
∂t
+
∂
∂x
(ρu) +
∂
∂y
(ρv) +
∂
∂z
(ρw) = 0 (B.4)
Using the nabla function:
∇ = i ∂
∂x
+ j
∂
∂y
+ k
∂
∂z
(B.5)
We can rewrite the continuity equation as:
∂ρ
∂t
+∇· (ρV ) = 0 (B.6)
Which, for incompressible flow i.e. constant density, further reduces to
∇·V = 0 (B.7)
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B.2 Equations of Linear Momentum
In a simliar manner to Appendix B.1 the linear momentum equation for Figure
B.1 states: ∑
F =
∂
∂t
(∫
Ω
V ρdV
)
+
∑
(m˙iVi)out −
∑
(m˙iVi)in (B.8)
Again the volume integral reduces to:
∂
∂t
(∫
Ω
V ρdV
)
≈ ∂
∂t
(ρV )dxdydz (B.9)
The table of momentum fluxes is also constructed in a similar vein to give
Face Inlet momentum flux Outlet momentum flux
x ρuV dy dz
[
ρuV +
∂
∂x (ρuV ) dx
]
dy dz
y ρvV dx dz
[
ρvV +
∂
∂y (ρvV ) dy
]
dx dz
z ρwV dx dy
[
ρwV +
∂
∂z (ρwV ) dz
]
dx dy
Table B.2: Table of control fluxes
Introducing these terms into eqns B.8 and B.9 we get
∑
F = dxdydz
[
∂
∂t
(ρV ) +
∂
∂x
(ρuV ) +
∂
∂y
(ρvV ) +
∂
∂z
(ρwV )
]
(B.10)
taking the term in the square bracket we can write
∂
∂t
(ρV )+
∂
∂x
(ρuV )+
∂
∂y
(ρvV )+
∂
∂z
(ρwV ) = V
[
∂ρ
∂t
+∇·(ρV )
]
+ρ
(
∂V
∂t
+u
∂V
∂x
+v
∂V
∂y
+w
∂V
∂z
)
(B.11)
The term in square brackets can be seen to be the continuity equation and so
vanishes. The longer term in the round brackets can be seen to be the acceleration
of a particle in the control volume and can be written
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∂V
∂t
+ u
∂V
∂x
+ v
∂V
∂y
+ w
∂V
∂z
=
dV
dt
(B.12)
and so eqn B.10 reduces to:
∑
F = ρ
∂V
∂t
dxdydz (B.13)
Figure B.2: Notation for stresses
Equation B.13 states the net force on the control volume must be of differen-
tial size and proportional to the element volume. These forces are of two types
surface forces or body forces. Body forces are due to some external force such
as gravity or electrical potential however surface forces are due to stresses on the
surfaces of the control volume and are te sum of the hydrpstatic stresses and the
viscous stresses τij
σij =

−p+ τxx τyx τzx
τxy −p+ τyy τzy
τxz τyz −p+ τzz
 (B.14)
The notation for which can be seen in Figure B.2 It should be noted that it is
not the stresses them sleves but rather thier gradients that cause the net force on
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Figure B.3: Control volume showing surface forces in x direction
the control volume. This can be seen from Figure B.3 the leftward force σxxdydz
is balanced by the rightward force σxxdydz on the right face leaving only the
net rightward force (∂σxx/∂x)dxdydz. This can be repeated for the other two
directions resulting in the net force in the x direction being given as
dFx,surf =
[
∂
∂x
(σxx) +
∂
∂y
(σyx) +
∂
∂z
(σzx)
]
dxdydz (B.15)
Substituting in values from eqn B.15 we get
dFx
dV
= −∂p
∂x
+
∂
∂x
(τxx) +
∂
∂x
(τyx) +
∂
∂x
(τzx) (B.16)
This can be repeated to give forces in both yand z
dFy
dV
= −∂p
∂y
+
∂
∂y
(τxy) +
∂
∂y
(τyy) +
∂
∂y
(τzy)
dFz
dV
= −∂p
∂z
+
∂
∂z
(τxz) +
∂
∂z
(τyz) +
∂
∂z
(τzz) (B.17)
Combining these equations we get
(
dF
dV
)
surf
= −∇p+
(
dF
dV
)
viscous
(B.18)
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where
(
dF
dV
)
viscous
= i
(
∂τxx
∂x
+
∂τyx
∂y
+
∂τzx
∂z
)
+j
(
∂τxy
∂x
+
∂τyy
∂y
+
∂τzy
∂z
)
+k
(
∂τxz
∂x
+
∂τyz
∂y
+
∂τzz
∂z
)
(B.19)
or
(
dF
dV
)
viscous
= ∇ · τij (B.20)
where
τij =

τxx τxy τxz
τyx τyy τyz
τzx τzy τzz
 (B.21)
Combining equations B.20 B.18 B.4 and by taking the gravity as the only
body force acting on the volume i.e. dFgrav = ρgdxdydz we get
ρg −∇p+∇ · τij = ρdV
dt
(B.22)
where
∂V
∂t
+ u
∂V
∂x
+ v
∂V
∂y
+ w
∂V
∂z
=
dV
dt
(B.23)
While equation B.22 looks relatively simple but when expanded to illustrate
the inherent complexity looks as follows
ρgx − ∂p
∂x
+
∂τxx
∂x
+
∂τyx
∂y
+
∂τzx
∂z
= ρ
(
∂u
∂t
+ u
∂u
∂x
+ v
∂u
∂y
+ w
∂u
∂z
)
ρgy − ∂p
∂y
+
∂τxy
∂x
+
∂τyy
∂y
+
∂τzy
∂z
= ρ
(
∂v
∂t
+ u
∂v
∂x
+ v
∂v
∂y
+ w
∂v
∂z
)
ρgz − ∂p
∂z
+
∂τxz
∂x
+
∂τyz
∂y
+
∂τzz
∂z
= ρ
(
∂w
∂t
+ u
∂w
∂x
+ v
∂w
∂y
+ w
∂w
∂z
)
(B.24)
If we assume incompressible flow we can use the following relationships
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τxx = 2µ
∂u
∂x
τyy = 2µ∂v∂y τzz = 2µ
∂w
∂z
(B.25)
τxy = τyx = µ
(
∂u
∂y
+
∂v
∂x
)
τxz = τzx = µ
(
∂w
∂x +
∂u
∂z
)
τyz = τzy = µ
(
∂v
∂z
+
∂w
∂y
)
to give the differential momentum equation for a Newtonian fluid with con-
stant density and viscosity
ρgx − ∂p
∂x
+ µ
(
∂2u
∂x2
+
∂2u
∂y2
+
∂2u
∂z2
)
= ρ
du
dt
ρgyx − ∂p
∂y
+ µ
(
∂2v
∂x2
+
∂2v
∂y2
+
∂2v
∂z2
)
= ρ
dv
dt
(B.26)
ρgz − ∂p
∂z
+ µ
(
∂2w
∂x2
+
∂2w
∂y2
+
∂2w
∂z2
)
= ρ
dw
dt
These equations are also known as the Navier-Stokes Equations
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